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Metabolic Pathway Analysis: Basic concepts and scientific applications in the post-
genomic era
Natural products have been of major interest due to their pharmaceutically 
exploitable properties like antibacterial (Christophersen, et al., 1998), antifungal 
(Coleman, et al., 2011), antiparasitic (Wink, 2012), anticancer (Nirmala, et al., 
2011) or immunosuppressive (von Wartburg and Traber, 1988) activities. Although 
not always used directly as a drug they act as a reliable source for novel and 
innovative therapeutic agents offering valuable chemical scaffolds for novel drugs 
(Newman and Cragg, 2007). The primary source of these structurally heterogenic 
molecules are natural sources like bacteria and fungi, which is not surprising as 
these microorganisms live in complex ecosystems where they compete and 
communicate with other organisms (Goh, et al., 2002; Losada, et al., 2009) Up 
till today, natural products represent the largest source of drugs offering novel 
chemical entities. Although newer techniques like combinatorial chemistry have 
been used as a discovery source for several years, solely one approved drug with a 
new chemical entity was reported to be discovered between 1982 and 2007 using 
this method (Newman and Cragg, 2007). In 2005, Bayer’s antitumor compound 
sorafenib, obtained from combinatorial chemistry, was approved by the FDA. This 
gives reason to expect that microorganisms will play also a major role in future drug 
developments.
However, the incredible increase in the amount of sequencing data, primarily driven 
by the falling cost of DNA sequencing, has led to a paradigm shift in the approach 
of secondary metabolite discovery (Letzel, et al., 2013). The analysis of the growing 
number of sequenced fungal genomes revealed that most of the genes responsible 
for secondary metabolite production are located in clusters which far outweigh 
the number of described secondary metabolites (Brakhage and Schroeckh, 2011). 
That means, that despite the discovery of countless natural products during the 
last decades a vast number of novel natural products with potent bioactivities 
based on novel structural features still awaits discovery. With the use of genome 
sequencing data unknown secondary metabolite clusters can be identified without 
a priori knowledge of a strain’s ability to produce natural products. This approach 
of secondary metabolite discovery is known as genome mining and has been 
successfully applied for the identification of various novel metabolites (Letzel, et 
al., 2013).
These metabolites are produced by large, multifunctional protein complexes called 
non ribosomal peptide synthetases (NRPS) or polyketide synthetases (PKS) which 
catalyze the stepwise condensation of simple amino acids or malonyl building 
blocks to complex molecules. Although their substrates can differ considerably, 
these multi-modular enzymes show striking similarities in their architecture as well 
as in the mechanisms used for product assembly. 
NRPSs have a modular organization, with each module responsible for one or more 
chain-elongation step. Every single module is subdivided into three basic domains 
that carry all essential information for recognition, activation and modification of 
one substrate. At a minimum, a typical NRPS module consists of an adenylation 







known as peptidyl carrier protein (PCP), which binds the activated amino acid and 
a condensation (C) domain that catalyzes peptide-bond formation. The common 
arrangements of these domains follow a (C-A-PCP)n organization. Additionally, a 
variety of optional domains have been described (Schwarzer, et al., 2003) such as 




























































































































































Figure 1. NRPS assembly of surfactin
The surfactin biosynthesis consists of seven modules each responsible for one chain-elonging step. Each module 
is divided in various domains catalyzing the activation (A domain), covalent binding (PCP domain), elongation (C 
domain), epimerization (E domain) and termination by covalent cyclization (TE domain).
A similar domain architecture can be found in PKS systems with an acyltransferase 
(AT) domain responsible for building block selection and transfer, an acyl carrier 
protein (ACP) for unit loading and a ketosynthase (KS) domain for decarboxylative 
condensation of the extending substrate. The resulting keto thioester can 
subsequently be modified by ketoreductase (KR) domains, dehydratase (DH) 
domains and enoyl reductase (ER) domains (Cane, 1997; Staunton and Weissman, 
2001). In addition, modular NRPS and PKS systems can closely cooperate to form a 
third group of gene clusters, so-called hybrid products.
The number of modules and their domain organization within the enzymes control 
the structures of the final products (Grunewald and Marahiel, 2006; Schwarzer, et 
al., 2003; Schwarzer, et al., 2002). Thus, the order of modules usually corresponds 
to the sequence of building blocks in the final product. Many systems adhere to this 
mechanistic paradigm, which is often referred to as the “co-linearity rule” (Fischbach 




the last years including iterative NRPS and PKS which incorporate multiple residues 
of the same unit iteratively into the final structure and the so called nonlinear 
NRPSs which deviate completely from the standard domain organization leading 
to unexpected products (Mootz, et al., 2002; Shaw-Reid, et al., 1999; Shen, 2003).
In 2008, the genome of Penicillium chrysogenum Wisconsin54-1255 was sequenced 
revealing 20 polyketide synthases (PKS), 10 nonribosomal peptide synthetases 
(NRPS) and 2 hybrid NRPS-PKS genes clusters (van den Berg, 2008). According to 
the deduced domain organization up to 20 polyketides, 10 nonribosomal peptides 
and two products with mixed properties are expected. However, most gene clusters 
encoding biosynthetic systems could not be associated with the production of a 
known metabolite and are therefore referred to as ‘cryptic’ or ‘orphan’.  The reason 
for the lack of assignment is that under standard laboratory conditions the majority 
of secondary metabolite biosynthesis gene clusters is not expressed (van den Berg, 
2011). These clusters remain silent as long as the triggers for their induction have 
not been identified. (Brakhage, et al., 2008). Furthermore, due to the complexity 
of these clusters almost no products could be directly deciphered from the genetic 
sequence with sufficient accuracy and confidence (van den Berg, 2011).
Strategies for the discovery of new natural products
Several strategies can be applied to elucidate the function of biosynthetic gene 
clusters, depending on the expression of latter (Challis, 2008). For expressed cryptic 
genes inactivation of a biosynthetic gene, which is presumed to be essential within 
the biosynthetic gene cluster, followed by comparative metabolite profiling of the 
wild-type organism and the non-producing mutant is the standard approach for 
defining the functions of genes and for the discovery of novel natural products 
(Brakhage and Schroeckh, 2011) (Figure 2). The metabolites present in the wild-
type but missing in the mutant are likely to be products of the cryptic gene cluster 
and can be isolated and structurally characterized. (Figure 2) Alternative strategies 
are applied when the gene cluster of interest is silent involving promoter exchange, 
overexpression of transcription factors or other pleiotropic regulators. (Brakhage 
and Schroeckh, 2011; Chiang, et al., 2011; Schumann and Hertweck, 2006)
All approaches combine an elaborate and refined strategy to discover, isolate, and 
characterize novel natural products. They all have in common that sensitive, accurate, 
quantitative and fast analytical techniques are required to detect differences in 
production related to the conducted genetic modification. Furthermore, due to the 
rapid advances in DNA sequencing technology it is conceivable that, in the recent 
future, thousands of cryptic natural product biosynthetic gene clusters will become 
available, leaving the discovery of the metabolic products of these clusters the 
bottleneck (Zerikly and Challis, 2009).
Metabolite discovery and metabolomics
The aim of metabolomics is to measure the full metabolome, which consists of all 
low molecular weight species in cells, tissues, organs or organisms (Griffin, 2004). 
Unlike the proteome, which represents the entire set of proteins, primarily build 
from 20 basic amino acids with a limited set of modifications and a rather defined 
distribution of physicochemical properties, are metabolites a highly diverse range 







over several orders of magnitude (pM – mM) combined with often a short lifetime 
represent metabolites a challenging class of compounds to analyze. Different 
from transcriptomics and genomics, which utilize polymerase chain reaction (PCR) 
to amplify DNA sequences, there is no effective tool to unbiasedly increase the 
concentration of all low abundant metabolites. Therefore, more than one analytical 
method is required for the acquisition of a comprehensive metabolite profile 
attempting to describe the global metabolism (van der Greef, et al., 2007). Even 
today, despite the rapid advances in technical instrumentation in the last years, no 
analytical tool is capable to completely cover the entire metabolome of even the 
simplest organism (Heather, et al., 2013).
The two most commonly used techniques in metabolomics are NMR spectroscopy 
and mass spectrometry. NMR is based on the measurement of isotopes that 
contain an odd number of protons and/or neutrons in a magnetic field. Typically, 
metabolites higher concentrated than 5-10 μM can be detected if they are not co-
resonant with higher concentrated metabolites. (Heather, et al., 2013). Despite 
this limited sensitivity (Martin, et al., 2007), NMR spectroscopy is widely used in 
metabolomics studies due to its speed, non-invasiveness and robustness and its 
highly quantitative nature. As the area of a peak is proportional to the concentration 
of the metabolite measured, determination of absolute concentrations is possible. 
In contrast, mass spectrometry (MS) techniques which measure molecules as ions 
in the gas phase after ionization, are fast and highly sensitive with a large dynamic 
range. By fragmenting these ions, structural information can be obtained supporting 
the identification of relevant metabolites (Dettmer, et al., 2007). As a wide range of 
different MS instruments are available, ranging from high resolution MS such as 
Fourier transform ion cyclotron resonance (FTICR), Orbitrap FT and time-of-light 
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Figure 2. Principle of a gene knockout strategy in combination with comparative metabolite profiling to elucidate 




(TOF) to low resolution MS (ion traps, triple and single quads) up to hybrid systems, 
various techniques with different emphasis can be applied.
However, mass spectrometry is most commonly coupled to chromatographic 
separation techniques like gas chromatography (GC-MS) and liquid chromatography 
(LC-MS) allowing the separation of complex mixtures into its individual components. 
By doing so, LC-MS and GC-MS exceed the sensitivity of NMR spectroscopy by many 
orders of magnitude. For these reasons, mass spectrometry is the primarily used 
technique in metabolomics studies currently outnumbering the application of NMR 
(Dettmer, et al., 2007).
For GC–MS, metabolites have to be volatile or made volatile using 
derivatization techniques. Especially small molecules like amino acids, 
sugars, glycolytic intermediates, fatty acids and TCA cycle intermediates 
can be detected after derivatization using derivatization reagents like 
N-methyltrimethylsilyltrifluoroacetamide (MSTFA). The most common ionization 
technique in GC-MS is electron ionization (EI) which produces, next to the radical 
molecule cation, characteristic fragments for many metabolites allowing their 
identification with databases like NIST or the Golm Metabolome Database (Kopka, et 
al., 2005).  While a robust and versatile technique, GC–MS is limited to compounds 
which are or can be made volatile and thermostable enough for application in 
the system. In cases where this cannot be achieved, LC–MS is an option which in 
principle does not require derivatization, allowing fast analysis.
Depending on the polarity of the analytes of interest, a suitable separation 
technique like normal-phase liquid chromatography (NPLC), reversed-phase liquid 
chromatography (RPLC) or hydrophilic interaction chromatography (HILIC) (Tolstikov 
and Fiehn, 2002) can be chosen for an efficient separation of the individual 
compounds. After chromatographic separation, the analytes are introduced into the 
mass spectrometer using an ionization technique like electrospray ionization (ESI) 
or less frequent atmospheric pressure chemical ionization (APCI) (Niessen, 2003). 
As minimal fragmentation takes place during ionization, the measured mass of an 
analyte, recorded with high mass accuracy and resolution, is expected to be close 
to the anticipated mass of a specific metabolite recorded in a publically accessible 
database which potentially allows a direct putative identification. Several databases 
containing metabolite information are available in order to facilitate putative 
annotation of accurate mass signals. (e.g. PubChem; HMDB; KEGG, KNapSAcK, 
MZedDB). 
Metabolite Profiling
Metabolomics experiments can be conducted as non-targeted profiling using an 
unbiased approach which aims to measure as many metabolites as possible. As the 
conditions are not optimized for a particular set of compounds, limits of detection 
can be severely impaired resulting, at worst, in a failure to detect and identify the 
desired metabolites.
If more information about the metabolites of interest is available, more targeted 
profiling approaches can be used focusing on a particular class of compounds. As the 
biosynthesis of secondary metabolites by PKS or NRPS systems underlays modular 
based mechanisms, bioinformatics tools can be used to predict substrates, their 







corresponding physiochemical properties facilitates the subsequent discovery of 
these natural products from biological origins as an appropriate targeted profiling 
method, optimized for their detection, can be selected. Often a non-targeted 
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Figure 3. Bioinformatics driven selection of an analytical approach for metabolite discovery
Prediction of the modular organization of a cryptic PKS/NRPS system in combination with calculated substrate spe-
cificities results in possible products synthesized by the biosynthetic gene cluster. Predicting their physiochemical 
properties can help to select appropriate analytical techniques for their detection. 
method which allows the determination of absolute concentrations. By identifying 
metabolites varying between wild-type and mutant samples using statistical 
methods like the Student’s t-test, analysis of variance (ANOVA) or principal 
component analysis (PCA), metabolic changes can be identified which are related 
to the genetic modification. This approach, called comparative metabolite profiling, 
is the most often used approach for the determination of metabolic differences 
(Fernie, et al., 2004). 
Structure elucidation in metabolomics
Metabolite identification is an essential part of any metabolomics study and 
frequently cited as the major bottleneck in metabolomics (Scalbert, et al., 2009). 
Without a proper identification, the discovery of metabolic alterations related 
to a biological question is uninterpretable and limited to diagnostic purposes 
only. However, as one of the most challenging and labor intensive parts in the 
metabolomics framework, metabolite identification is neglected in many studies or 
even completely ignored as the distinctive versatility of metabolites, with millions 
of possible structures even matching a given elemental composition, imposes a 
major challenge. 
Commonly, complementary analytical techniques like NMR, IR, UV, MS, etc. are 




spectrometry in combination with various fragmentation techniques represents one 
of the most routinely used techniques for metabolite identification as it requires 
small sample volumes, low sample concentrations and purity and short analysis 
times. By fragmenting ionized molecules and detect their charged fragments 
structural information can be obtained. Using this approach in combination with 
the identified elemental composition of a metabolite, MS/MS databases can be 
built and screened in order to match an identical database entry (Horai, et al., 
2010; Wishart, et al., 2009). However, different levels of identification are defined 
depending on the available metadata (Sumner, et al., 2007). Whereas on level 1 two 
independent and orthogonal techniques are required for a full identification of a 
non-novel metabolite using a reference compound, represents a level 2 identification 
a putatively annotated compound without chemical reference standards available 
but identity to metadata from an entry in a database. A level 3 identification is the 
putatively characterization of a compound based on similarities to a specific class of 
compounds. Metabolites identified at level 4 represent unknown compounds which 
can be differentiated and quantified but are structurally not characterized.
Scope of the thesis 
The aim of this thesis is to demonstrate how to discover, identify and ultimately assign 
novel secondary metabolites with new structural features harboring potentially 
pharmaceutically exploitable properties to their corresponding NRPS and/or PKS 
gene clusters in Penicillium chrysogenum using genome mining strategies. For this, 
an adequate analytical pipeline is required which allows the unbiased detection 
of genetic modifications on a metabolic level. As products and intermediates of 
secondary metabolite gene clusters show complex chemical structures and are 
mostly present only at low concentrations, an advanced mass spectrometry based 
pipeline was developed which enables the identification of structural complex 
metabolites at low concentrations directly from a biological matrix. 
Outline of the thesis
In Chapter 2, the validation and further application of a targeted profiling method 
is described for the identification of secondary metabolites originating from a 
cryptic di-modulated NRPS gene cluster. As bioinformatics analysis of the gene 
cluster predicted various modified dipeptides involved in the biosynthetic pathway, 
a reversed phase based separation method was developed. After structure 
elucidation of metabolites using NMR and MS/MS based techniques, detailed 
enzymatic reaction steps were identified and their corresponding genes assigned.  
In Chapter 3, the identification of structurally novel compounds originating from the 
roquefortine/meleagrin pathway is described and their impact on the previously 
proposed pathway discussed. As a results, new biosynthetic reactions were found, 
indicating excessive branching of the previously as linear reported pathway, with 
several pharmaceutically interesting end products. 
The application of the secondary metabolite profiling pipeline for samples derived 
from genetic modifications of a cryptic tetra-modular NRPS system is subject of 
Chapter 4. As this non-linear NRPS lacks distinctive substrate specificity, various 







thus making their discovery and identification challenging. In combination with 
substrate predictions, a detailed biosynthetic mechanism is proposed.
In Chapter 5, a novel mass spectrometry based structure elucidation pipeline for the 
de novo structure identification of small molecules, coined CMCP (Chemoinformatics 
supported MSn  Comparison Pipeline) is presented. By transferring fragmentation 
mechanisms from a similar fragmenting database entry, complete structures could 
be identified solely using mass spectrometry. To demonstrate the various concepts 
of fragmentation tree comparison, the de novo identification of structurally 
complex secondary metabolites, obtained from comparative metabolite profiling 
from Chapter 2 and 3, is described. 
In Chapter 6, the application of CMCP in direct infusion based experiments is 
demonstrated. Challenges and advantages resulting from the lack of a separation 
step prior MS analysis are discussed. To demonstrate the capabilities of this 
approach to cope even with co-fragmenting interferences like isobaric and isomeric 
ions, the structure elucidation of various complex metabolites from liquid cultures 
of Penicillium chrysogenum is described using DI-MS in combination with CMCP.
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Profiling and structural elucidation of secondary metabolites produced by the 
filamentous fungus Penicillium chrysogenum and derived deletion strains were used 
to identify the various metabolites and enzymatic steps belonging to the roquefortine/
meleagrin pathway. Major abundant metabolites of this pathway were identified 
as histidyltryptophanyldiketopiperazine (HTD), dehydrohistidyltryptophanyldi-
ketopiperazine (DHTD), roquefortine D, roquefortine C, glandicoline A, glandicoline 
B and meleagrin. Specific genes could be assigned to each enzymatic reaction step. 
The nonribosomal peptide synthetase RoqA accepts L-histidine and L-tryptophan 
as substrates leading to the production of the diketopiperazine HTD. DHTD, 
previously suggested to be a degradation product of roquefortine C, was found to 
be derived from HTD involving the cytochrome P450 oxidoreductase RoqR. The 
dimethylallyltryptophan synthetase RoqD prenylates both HTD and DHTD yielding 
directly the products roquefortine D and roquefortine C without the synthesis of 
a previously suggested intermediate and the involvement of RoqM. This leads 
to a branch in the otherwise linear pathway. Roquefortine C is subsequently 
converted into glandicoline B with glandicoline A as intermediates, involving two 
monooxygenases (RoqM and RoqO)  which were mixed up in an earlier attempt 
to elucidate the biosynthetic pathway. Eventually, meleagrin is produced from 
glandicoline B involving a methyltransferase (RoqN). It is concluded that roquefortine 
C and meleagrin are derived from a branched biosynthetic pathway.
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Fungi produce a variety of secondary metabolites, which have diverse activities, 
ranging from natural antibiotics to simple toxins or immunosuppressants (Demain 
and Fang, 2000). Most of these metabolites are synthesized either by nonribosomal 
peptide synthetases (NRPS) or polyketide synthases (PKS) and can be further modi-
fied by a range of biosynthetic enzymes. The genes encoding the NRPS or PKS and 
the modifying enzymes are usually located in the same genetic region and are often 
co-expressed (Keller, et al., 2005; Shwab and Keller, 2008). Several methods have 
been developed to identify the secondary metabolite biosynthetic gene clusters 
and their respective products. Key methods are heterologous gene expression, bioi-
nformatic (SMURF) identification of gene clusters (Khaldi, et al., 2010) and genome 
mining strategies in which core synthetase genes are deleted and changes in meta-
bolite production are identified by comparative metabolite profiling (Challis, 2008).
Secondary metabolites genes and/or their clusters were frequently transferred 
from one organism to another during evolution (Donadio, et al., 2005; Fischbach, 
et al., 2008). The distribution of these clusters in fungal genomes supports the hy-
pothesis that different organisms produce similar metabolites (Ma, et al., 2010). 
Various fungal species were reported to produce diketopiperazines, a class of phar-
maceutically important naturally produced secondary metabolites (Maristela and 
Carvalho, 2007; Scherlach and Hertweck, 2006). Roquefortine C, a diketopiperazine 
that was first isolated from Penicillium roquefortine (Scott and Kennedy, 1976) has 
now been reported from 25 different Penicillium species (Frisvad, et al., 2004). It 
displays bacteriostatic activity against Gram-positive bacteria (Kopp-Holtwiesche 
and Rehm, 1990). Although the exact mechanism of action is not known it appears 
to interact with cytochrome p450 and interferes with RNA synthesis (Aninat, et al., 
2001; Kopp and Rehm, 1981). Roquefortine C also shows neurotoxic activity in mice 
and is considered as a contaminant in blue cheese (Polonsky, et al., 1977; Scott, et 
al., 1979). Meleagrin, a downstream product of roquefortine C, has been proposed 
to be the precursor of neoxaline, a compound with antimicrobial activity (Overy, et 
al., 2005).
The filamentous fungus P. chrysogenum has been explored for more than eighty 
years for its excellent fermentation capacity and penicillin production (Fleming, 
2001; Weber, et al., 2012). In recent years, genome sequencing, as well as microar-
ray analysis in combination with genetic modification of P. chrysogenum, has provi-
ded a strong base to elucidate the role of the secondary metabolite clusters found 
in this organism. The genome of P. chrysogenum encodes 20 putative PKS and 11 
NRPS genes including the gene encoding δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine 
synthetase involved in penicillin biosynthesis (van den Berg, et al., 2008). This al-
lowed us to identify the corresponding biosynthetic genes of the roquefortine/me-
leagrin pathway using a gene deletion strategy as well as quantitative metabolite 
profiling. Here, we revisit an earlier proposal for a linear pathway for the biosynthe-
sis of roquefortine C that included several ambiguities as well speculations because 
of incomplete metabolite profiling and enzyme miss assignment. We have elucida-
ted the entire biosynthetic pathway up to meleagrin production including a series of 
precursors. It is demonstrated that meleagrin is derived from a branched pathway 






HPLC-grade acetonitrile and methanol were purchased from Biosolve (the Nether-
lands). Dichloromethane, formic acid the internal standards reserpine, ranitidine 
and ampicillin were acquired from Sigma-Aldrich (St. Louis, MO). Meleagrin and 
neoxaline were purchased from Bio-Connect (the Netherlands). Roquefortine C was 
obtained from Bioaustralis (Australia). L-Tryptophan, L-Histidine and Mevalonic acid 
Lactone were purchased from Sigma-Aldrich. All purchased compounds were of hi-
ghest available purity.Animal studies
Host strains, media, grown condition and plasmid construction
P. chrysogenum strain DS54555, which lacks penicillin cluster genes and Ku70 
gene was used as a host strain for deletion analysis and was kindly supplied by 
DSM Anti-infective. All the strains were grown on YGG-medium (Kovalchuk, et al., 
2012) for protoplasts formation and transformation. For analysis, cells were grown 
on SMP medium (glucose, 5.0 g/L; lactose, 75 g/L; urea, 4.0 g/L; Na2SO4, 4.0 g/L; 
CH3COONH4, 5.0 g/L; K2HPO4, 2.12 g/L; KH2PO4, 5.1 g/L) for secondary metabolites 
production using a shaking incubator at 200 rpm for 168 hours at 25°C. Deletion 
plasmids were constructed by amplifying the flanking regions of the targeted gene 
with the Multisite Gateway®Three-Fragment Vector Construction Kit (Invitrogen). 
Escherichia coli DH5α was used as host strain for high frequency transformation 
and plasmid DNA amplification (Sambrook, et al., 1989). Tryptophan, histidine and 
mevalonic acid lactone were dissolve in the same phosphate buffer as used in the 
culture medium. 
Transformation procedure
Deletion plasmids were transformed to the protoplasts of P. chrysogenum strain 
DS54555 (Alvarez, et al., 1987). The phleomycin resistance gene was used as selec-
tion marker for the deletion of roqA, roqT and roqD while acetamidase gene (amdS) 
was used as selection marker for the deletion of roqM, roqO, roqN and roqR using 
acetamide as the only nitrogen source for selection (Kolar, et al., 1988; Kovalchuk, 
et al., 2012).
Genomic DNA extraction, total RNA extraction and cDNA amplification
Genomic DNA (gDNA) was isolated after 96 hours of growth on SMP medium using 
the modified yeast gDNA isolation protocol (Harju, et al., 2004) in which the fun-
gal mycelium is broken in a FastPrep FP120 system (Qbiogene). Isolated gDNA was 
measured using a NanoDrop ND-1000 and 5 µg was used for southern hybridiza-
tion. Total RNA of the host strain was isolated after 168 hours of growth in SMP 
medium using Trizol (Invitrogen), with additional DNase treatment using the Turbo 
DNA-free kit (Ambion). Total RNA was measured with the NanoDrop ND-1000 and a 
concentration of 500 ng per cDNA reaction was used. cDNA was synthesized using 
the iScript cDNA synthesis kit (Bio-Rad) in a 10-μl end volume.
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gDNA of the host and various deletion strains was isolated using the E.Z.N.A. Fungal 
DNA kit (Omega Bio-tek). Southern blotting was carried out by digesting gDNA (5 
μg) with the indicated restriction enzymes. Digested DNA fragments were separa-
ted on a 0.8 % agarose gel and blotted onto a Zeta-Probe membrane (Biorad) des-
cribed earlier (Nijland, et al., 2008), and hybridized with the indicated probes that 
were DIG labeled.
qPCR analysis 
The primers used to analyze the expression of all the genes in the Roquefortine/
Meleagrin biosynthetic gene cluster i.e. Pc21g15480 (roqA), Pc21g15420 (roqT), 
Pc21g15430 (roqD), Pc21g15440 (roqT), Pc21g15450 (roqN), Pc21g15460 (roqO) 
and Pc21g15470 (roqR) were designed around an intron to avoid amplification on 
gDNA (Table S3). For expression analyses, the γ-actin gene was used as a control 
for normalization. A negative reverse transcriptase (RT) control was used to deter-
mine the gDNA contamination in isolated total RNA. The expression levels were 
determined in triplicate with a MiniOpticon system (Bio-Rad) using the Bio-Rad CFX 
manager software, with in which the threshold cycle (CT) values were determined 
automatically by regression. The SensiMix SYBR mix (Bioline) was used as a mas-
ter mix for qPCR with 0.4 µM primers. The following thermocycler conditions were 
used: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C 
for 30 s. Subsequently, a melting curve was generated to determine the specificity 
of the qPCRs.
Microarray methods
Triplicate shake flask cultivations were performed with the P. chrysogenum strain 
DS17690 to prepare a proprietary DNA microarray, using the Affymetrix Custom Ge-
neChip program (Affymetrix): After 90 hours of cultivation, samples from shake flask 
cultures were filtered within seconds and quenched in liquid nitrogen. A standard 
protocol using Trizol reagent (Invitrogen) and acid phenol-chloroform was used to 
extract the total RNA followed by cDNA synthesis and cRNA synthesis. Hybridized 
arrays were scanned and analyzed using the Affymetrix GeneChip Operating Soft-
ware (GCOS, Affymetrix) as described earlier by van der Berg et al. (van den Berg, 
et al., 2008). 
HPLC-MS validation and analysis - Sample preparation
All strains used for gene assignments were grown in quintuplicate according to 
the procedure described above. Samples for determination of growth curves were 
grown in eight replicates whereas feeding experiment samples were grown in qua-
druplicate. Up to 50 µL of a thawed fermentation broth, 8 µL internal standard mix-
ture containing 855 nmol/mL ranitidine, 657 nmol/mL reserpine and 1144 nmol/mL 
ampicillin was added. Subsequently, 230 µL of methanol was added for protein pre-
cipitation and vortexed for 10 minutes. The sample was then centrifuged at 14,000 
g for 10 minutes at 10°C. 100 µL supernatant was transferred to an Eppendorf vial 
and evaporated for 30 minutes in a Thermo-Speedvac (Thermo Scientific, San Jose, 
CA). The dried sample was redissolved in 100 µL water containing 2 % acetonitrile, 





For separation, an Agilent 1200 Capillary pump (Agilent, Santa Clara, CA) coupled 
to a Surveyor PDA detector (Thermo Scientific, San Jose, CA) and LTQ-FT Ultra mass 
spectrometer (Thermo Scientific, San Jose, CA) were used. A sample of 5 µL was 
injected onto a Waters Atlantis T3 column (2.1 x 100 mm, 3 µm) (Waters, Milford, 
MA). The elution was performed with a linear gradient starting with 98 % of solvent 
A (1 % acetonitrile and 0.1 % formic acid in water) and 2 % solvent B (1 % water and 
0.1 % formic acid in acetonitrile) for 1.5 minutes at a flow rate of 300 µL/min. The 
first linear gradient reached 40 % B at 22 minutes, the second 100 % B at 25 minu-
tes. The column was flushed for 10 minutes at 100% B followed by equilibration for 
8 minutes at 100 % A. The column effluent was directed to the ESI-LTQ-FT Ultra MS, 
operated in full scan (m/z 100-2000) in pos/neg switching mode with following set-
tings: Positive ion mode (4kV source voltage, 14V capillary voltage, 65V tube lens), 
negative ion mode (3kV source voltage, -18V capillary voltage, -85V tube lens) with 
capillary temperature 275°C, sheath gas flow 50 and auxiliary gas flow 2.
Data Processing
Raw files were sliced into UV-trace, positive and negative mass trace and subse-
quently converted into NetCDF, using an in-house tool programmed in MATLAB (Ma-
thWorks, Natick, MA). NetCDF files with same polarity were subsequently decon-
voluted in DataAnalysis 4.0 (Bruker Daltonik, Bremen, Germany) using the dissect 
function which was controlled through a macro. The resulting peak tables for each 
sample were combined and repeating features removed. The combined feature ta-
ble was used as target list in which each feature was integrated in every individual 
sample. Samples were grouped regarding their biological origin and statistical tests 
were performed for determination of significant differences. Discovered features 
were selected and transferred to LCquan v2.6 (Thermo Scientific, San Jose, CA) for 
more accurate integration. Peaks were auto-integrated using base peak trace in a 
mass range of 10 ppm and retention time window of 60 seconds and manually cor-
rected if necessary.
Secondary metabolite identification
The identity of 7 and 4 was confirmed by comparing retention time and HR-MSn 
spectra of samples to commercially available standards. The structure of 1 was de-
termined by Mass Spectrometry (MS2 fragmentation and fragmentation tree com-
parison) as will be detailed elsewhere which was adapted from the metabolite iden-
tification pipeline developed with the Netherlands Metabolomics Centre (Kasper, et 
al., 2012; Rojas-Cherto, et al., 2012). 
Compound 2, 3 and 6 were identified by NMR. 3 and 6 were extracted based on a 
modified method of Ohmomo (Ohmomo, et al., 1980). A P. chrysogenum culture fil-
trate was made alkaline with 25 % ammonium hydroxide (pH 10) and extracted with 
dichloromethane. The alkaline dichloromethane layer was evaporated to dryness, 
redissolved in water containing 50 % acetonitrile, vortexed, centrifuged and trans-
ferred to an autosampler vial for fraction collection via preparative reversed phase 
LC on an Atlantis T3 column (10 x 100mm, 5 µm ) (Waters Milford, MA). Compound 
2 was extracted following the isolation procedure above except using ethylacetate 
as extraction solvent instead of dichloromethane. 
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NMR spectra were recorded on a Bruker Avance III 700 MHz NMR spectrometer, 
equipped with a 5 mm TCI probe. Samples were dissolved in 0.6 mL DMSO/CDCl3 
50/50 and acquired at 280K (2 and 3) and 320K (6).
 
Results
Identification of roquefortine biosynthetic gene cluster
In order to identify the secondary metabolite biosynthetic genes under shake flask 
culture conditions, DNA microarray analysis was performed on the high penicillin 
yielding P. chrysogenum strain DS17690 grown in the presence and absence of the 
precursor phenylacetic acid (PAA). Most of the secondary metabolite gene clusters 
were not expressed or only at low levels (van den Berg, et al., 2008). However, 
high levels of expression were observed in the absence of PAA for a gene cluster 
including the nonribosomal peptide synthetase PC21g15480 (roqA), and associa-
ted genes Pc21g15420 (roqT), Pc21g15430 (roqD), Pc21g15440 (roqN), Pc21g15450 
(roqO), Pc21g15460 (roqM) and Pc21g15470 (roqR) (Figure 1A). These genes were 
all down regulated when the cells were grown in the presence of PAA and hence 
are considered as co-regulated in the genome (Figure 1B). For the remainder of the 
study these genes were abbreviated as roq genes because of their involvement in 
roquefortine production.
Untargeted secondary metabolite profiling by HPLC-UV-MS 
A robust and sensitive quantitative platform for profiling of secondary fungal me-
tabolites from culture broth was developed, validated and applied. As the majority 
of these compounds are unknown and often present at low concentrations only, 
the method should be sensitive and provide a high degree of versatility. Herein, 
we used a high resolution HPLC-UV-MS method with positive/negative ionization 
switching in combination with UV to allow for the detection of several thousand 
features. To extract these features from the acquired data, a combination of com-
mercial software packages and in-house scripts were used for untargeted peak 
discovery and automatic peak integration. By applying a deconvolution algorithm, 
fragments, adducts and cluster ions as well as their isotopes were grouped and 
altogether represented mainly by the most abundant ion in the resulting target list 
which facilitated further data analysis. 
The method was validated in which several analytical performance characteristics 
were determined, but here merely the most important outcomes are reported. As 
secondary metabolites from the roquefortine/meleagrin pathway showed much hi-
gher ionization efficiency in the positive ion mode, only this polarity is described 
here. For the determination of linear dynamic range, sensitivity and reproducibi-
lity, retention times and signal intensities were evaluated for the used (internal) 
standards at multiple concentrations. These standards comprised of commercially 
available compounds from the meleagrin/neoxaline pathway (neoxaline, meleagrin 
and roquefortine C) and a non-related non-endogenous compound (ranitidine), 
which was used as internal standard. Retention time variations for the standards 
and several “unknown” endogenous compounds, which are spread over the entire 
chromatogram of 35 minutes, were limited to maximal 7 seconds (500 injections 









roqT roqD roqN roqO roqM roqR roqA
A T C A T C











Pc21g15420  (roqT) Major facilitator superfamily transporter
Pc21g15430  (roqD) Dimethylallyl tryptophan synthase
Pc21g15440  (roqN) Methyltransferase
Pc21g15450  (roqO) Cytochrome P450 monooxygenase
Pc21g15460  (roqM) MAK1- like monooxygenase
Pc21g15470  (roqR) Cytochrome P450 oxidoreductase







































Figure 1. Organization of the roquefortine/meleagrin biosynthetic gene cluster and transcriptomic analysis. 
A: Roquefortine/meleagrin biosynthetic gene cluster and their orthologs in phylogenetically
relative species. Homologous proteins are indicated with the same color. 
B: Microarray analysis of the roquefortine biosynthetic genes in P. chrysogenum DS54555 using shake flask cul-
ture conditions in the absence (-) or presence (+) phenylacetic acid (PAA). 
C: Correlation between the expression level of roqA and the concentration of the product HTD (1) present in the 
growth media. The concentration of 1 was determined by HPLC-UV-MS.
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over at least 3 orders of magnitude (R² ranged from 0.998 – 0.999 in both, acade-
mic and spiked matrix samples) in the appropriate concentration range. Associated 
Limit of Detections (LOD’s) were determined from internal standard corrected ca-
libration lines (8 levels) and ranged from 3-248 nM, depending on the compound 
of interest. Due to the absence of endogenous material in the roqA deletion strain 
used for validation, absolute quantitation at the reported low levels is realistic.
The recovery of the method was determined primarily by the extraction of the spi-
ked compounds from the matrix, i.e., fermentation broth. Recoveries ranged from 
88 % (rsd 7.8 %) to 55 % (rsd 2.9 %) depending on the compound. However, repro-
ducibility measurements showed that both within day and between day reproduci-
bility are well below 15 %. In summary, the analytical profiling platform developed 
here is characterized by good reproducibility and linearity, high coverage and high 
sensitivity reaching nanomolar levels.
Metabolite profiling of the culture broth of a P. chrysogenum strain with a deletion 
of the nonribosomal peptide synthetase gene roqA
In order to identify secondary metabolites synthesized by RoqA, its gene was de-
leted and comparative metabolite profiling was performed on the culture super-
natant of the host and deletion strain. RoqA is specified by a 7.45 kbp long gene 
that translates into synthetase (2372 amino acids) with the typical domain motifs 
of nonribosomal peptide synthetases (NRPS). RoqA comprises two adenylation (A), 
thiolation (T) and condensation (C) domains arranged as ATCATC (Figure 1A) (van 
den Berg, et al., 2008). A host strain P. chrysogenum DS54555 was used which de-
rived from a DS17690 strain lacking the Ku70 gene and thus competent for homolo-
gous recombination. The DS54555 strain lacks all penicillin biosynthetic genes clus-
ters, which facilitates the identification of unknown secondary metabolites in the 
culture broth as the profile is no longer dominated by β-lactam compounds. RoqA 
was deleted by homologous recombination using the deletion plasmid pDEST R4-
R3a (Figure S1A) containing the phleomycin resistance gene surrounded by flanking 
regions of roqA. The deletion of roqA was confirmed by southern blot hybridization 
(Figure 2A). The host and ∆roqA strain were grown for 168 hours in secondary me-
tabolite production medium (SMP Medium) and comparative metabolite analysis of 
these strains was carried out by HPLC-UV-MS (Figure S2). This revealed the loss of 
several secondary metabolites in the deletion strain as compared to the host strain. 
These metabolites were identified as histidyltryptophanyldiketopiperazine (HTD) 
(1), dehydrohistidyltryptophanyldiketo-piperazine (DHTD) (2), roquefortine D (3), 
roquefortine C (4), glandicoline B (6) and meleagrin (7). The structures of all com-
pounds, except 1 were confirmed by LC-MS2 analysis and subsequent fragmentation 
spectra, by retention time comparison with their extracted standards as well as by 
NMR (Figure 3, Figures S3, S4, S5 and S6, Table S1). The m/z value for the compound 
1 identified as HTD was observed at 324.144 dalton representing the protonated 
molecule MH+ with formula C17H18N5O2. Its chemical structure was elucidated using 
LC-MS2 and high-resolution multi-dimensional fragmentation tree comparison. In 
addition, a protonated molecule MH+ at m/z 404.171 and formula C22H22N5O3, which 
coincides with the protonated form of glandicoline A (5), was observed to be pre-
sent in the host strain but absent in the deletion strain. Although, a full structure 
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MS2 which indicated consistency with the chemical structure of glandicoline A (e.g. 
dimethylallyl group) (Figure S3E). Hence, this ion was assumed to correspond to 
protonated glandicoline A. In conclusion, the loss of the identified secondary meta-
bolites in the deletion strain proves unequivocally that RoqA is responsible for the 
initial reaction in the roquefortine/meleagrin pathway by combining L-tryptophan 
and L-histidine to 1.
Biochemical analysis of P. chrysogenum harboring a deletion of the roqR gene
In order to elaborate the putative associated genes of the roquefortine/meleagrin 
biosynthetic pathway, the roqR gene encoding a putative cytochrome P450 oxido-
reductase was deleted. Herein, a linearized deletion plasmid pDEST R4-R3r (Figure 
S1B) was transformed into the protoplast of the host strain using the Aspergillus 
nidulans acetamidase gene (amdS) for the positive selection of transformants gro-
wing on media with acetamide as a sole nitrogen source. The homologous recombi-
nation resulted in the complete deletion of the roqR gene as demonstrated by Sou-
thern blot hybridization (Figure 2B). Both the host and ∆roqR strains were grown as 
described above. Deletion of roqR resulted in an accumulation of compound 1 and 
3 while 2, 4, 5, 6 and 7 were completely absent in the HPLC-MS profile of the ∆roqR 
strain (Figure 4A). These data suggest that 1 is a precursor of 2 resulting in a branch 
of the initially proposed linear pathway.
Biochemical analysis of P. chrysogenum with a deletion of the roqD gene
RoqD shares high sequence homology with dimethylallyltryptophan synthetase 
(DMATs). Transcriptional analysis of roqD showed high expression in the host strain 
grown in the absence of PAA in shake flasks (Figure 1B). To examine the role of RoqD 
in the biosynthesis of roquefortine and related metabolites, its gene was deleted 
with plasmid pDEST R4-R3d (Figure S1C) using phleomycin as a selection marker (Fi-
gure 2C). The deletion strain accumulated high levels of 1 (Figure 4B) in the culture 
broth as it was unable to add the dimethylallyl group needed for the conversion 
from 1 to 3. Moreover, the biosynthesis of the other (downstream) metabolites 3 
Figure 3. Total ion chromatogram for culture broth of P. chrysogenum
Total ion chromatogram (TIC, black) and normalized extracted ion chromatograms (EIC, colored) of secondary me-
tabolites from the roquefortine/ meleagrin pathway in the culture broth of P. chrysogenum DS54555. HTD (1, 8.8 
min), DHTD (2, 9.4 min), glandicoline A (5, 16.8 min), roquefortine D (3, 18.3 min), glandicoline B (6, 18.4 min), 







Figure 4. Internal standard corrected concentrations (RR = response ratio) of secondary metabolites from roque-
fortine/meleagrin pathway. 
The metabolite concentrations in the culture broth of the ΔroqR (A), ΔroqD (B), ΔroqM (C), ΔroqO (D), ΔroqN (E) 
and ΔroqT (F) strains was compared to the host strain P. chrysogenum DS54555.
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until 7 did not occur, while 2, which is similar in structure to compound 1, was six 
times higher in concentration as compared to the host strain. In combination with 
the roqR gene deletion, we conclude that RoqD is responsible for the conversion of 
1 to 3 (see Discussion).
Biochemical analysis of P. chrysogenum strains with a deletion of roqM, roqN and 
roqO gene
RoqM shows homology to MAK1-like monooxygenases. Its gene was deleted with 
the deletion plasmid pDEST R4-R3m (Figure S1D) using amdS as selection marker 
(Figure 2D). The deletion of roqM led to substantial accumulation of 3 and 4 com-
pared to the host strain whereas (downstream) metabolites like 5 till 7 were not 
detected (Figure 4C). This demonstrates that roqM is involved in the synthesis of 5 
using 4. 
RoqO shows homology to cytochrome P450 monooxygenases, and its gene was de-
leted using plasmid pDEST R4-R3o (Figure 2E, Figure S1E) using amdS as selection 
marker. Metabolite profile comparison of the host and deletion strain showed simi-
lar concentrations of 5 and its upstream metabolites in both strains (Figure 4D). The 
absence of 6 and 7 in the deletion strain suggests 5 as final product and therefore 
indicates a role of roqO in the biosynthesis of 5 to 6. 
RoqN specifies a putative methyltransferase. pDEST R4-R3n (Figure S1F) was used 
for the deletion of roqN using amdS for the positive selection of transformants (Fi-
gure 2F). The deletion of roqN resulted in the loss of 7 in fermentation broth (Figure 
4E). In addition, the concentration of 6 was increased sixty times compared to the 
host strain. This increase confirms that RoqN is responsible for the conversion of 6 
to 7 (Garcia-Estrada, et al., 2011).
Biochemical analysis of P. chrysogenum harboring a deletion of the roqT gene
RoqT shows high sequence homology with transporters of the major facilitator su-
perfamily. The gene was removed from the genome (Figure 2G) using deletion pla-
smid pDEST R4-R3t (Figure S1G) and phleomycin as selection marker. Remarkably, 
the strain with a deletion of roqT did not show any marked changes in the meta-
bolite profile as compared to host strain (Figure 4F), except that the production of 
3 was increased five times whereas production of 4 was decreased by 60 %. This 
indicates that roqT is not essential for the biosynthesis of 1 till 7.
Gene expression and secondary metabolite production
To relate the extracellular metabolites of the roquefortine/meleagrin pathway to 
the expression levels of the biosynthetic genes, the host strain was grown for 216 
hours in secondary SMP medium. Total mRNA extraction and extracellular meta-
bolites analysis were carried with samples collected during growth. The metabo-
lite concentrations were determined by HPLC-UV-MS, while transcript levels were 
determined by quantitative PCR using γ-actin as reference gene (Figure 1C, Figures 
S7and S8). The expression levels of the various biosynthetic genes increased linear 
in time, except for roqA that was found to be highly up-regulated after 96 hours 
when the cells are in the late log phase. The concentration of metabolite 1 synthe-
sized by RoqA increased almost equally with the expression levels of roqA (Figure 




decreased (Figure S7 and S8). The concentration of 4 dropped significantly already 
after 168 hours. The production of all metabolites was particularly high after 96 
hours of growth. It is concluded that the production of these metabolites is a late 
event during growth and that it correlates with the expression of the respective 
biosynthetic genes.
Precursor feed stimulates metabolite production
To evaluate the role of the predicted precursors in roquefortine/meleagrin pa-
thway and related metabolites production, feeding experiments were performed. 
L-Tryptophan, L-histidine and mevalonic acid lactone were added individually and 
in combination (at high and low concentration, i.e., 30 and 10 mM respectively) to 
the cultures. Since the production of 7 and most of its derivatives is most signifi-
cant around 96 hours of growth, precursors were added at that time point. Filtered 
supernatants were analyzed on HPLC-UV-MS after 168 hours of growth. The meta-
bolites concentrations were dry weight corrected and compared via t-test to sam-
ples without precursors addition. The concentration of metabolites 1 till 7, except 
4 increased with the addition of 10 mM tryptophan (Figure 5). Addition of 30 mM 
tryptophan increased the production of 1, 2, 3, 5 and 7 while addition of histidine, 
mevalonic acid lactone and combinations of tryptophan and histidine did not reveal 
any significant increase. These data suggest that the roquefortine biosynthetic pa-
thway is limited by the availability of tryptophan.





























tryptophan + histidine (l)
tryptophan + histidine (h)
mevalonic acid lactone (l)
mevalonic acid lactone (h)
Figure 5. Change in production of roquefortine/meleagrin metabolites after precursor addition
compared to production in cultures without addition. Colored cells show mean levels that are significant (P < 0.05) 
different.
Discussion
Here we have elucidated the biosynthetic pathway of P. chrysogenum responsible 
for the production of roquefortine, meleagrin and related compounds. Through a 
combined metabolic profiling, MS- and NMR based structure elucidation and gene 
inactivation analysis (7 genes in total, including a transporter-encoding gene); indi-
vidual genes could be assigned to the various biosynthetic steps. The architecturally 
complex roquefortine and meleagrin scaffolds are synthesized from simple building 
blocks, i.e. histidine and tryptophan. 
RoqA is a di-modulated NRPS, containing two adenylation domains (van den Berg, 
et al., 2008) responsible for the condensation of tryptophan and histidine to pro-
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duce 1, a diketopiperazine. The roqA deletion strain no longer produced any of the 
roquefortine related metabolites (1 till 7 absent from the broth) which was also 
recognized by García-Estrada et al. (Garcia-Estrada, et al., 2011). Therefore, roqA 
encodes the core enzyme initiating the biosynthesis of 1 till 7 and it is present in all 
species reported to produce these compounds (Frisvad, et al., 2004; Nielsen, et al., 
2006). RoqD encodes a dimethylallyltryptophan synthase catalyzing the reversed 
prenylation of 1 at the C3 position in its indole moiety utilizing dimethylallyl dip-
hosphate derived from mevalonic acid lactone  of the mevalonate pathway to form 
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the diketopiperazine moiety (Ohmomo, et al., 1975). Both conversions seem to oc-
cur simultaneously, similar to the formation of aszonalenin from benzodiazepinedi-
one, as no intermediate could be observed (Yin, et al., 2009). No prenylated cyclo-
histidyltryptophanyl-diketopiperazine was detected in both the host and deletion 
strain as previously suggested (Garcia-Estrada, et al., 2011). The latter we attribute 
to a lack of convincing analytical evidence in that particular study that indeed this 
compound is formed. Importantly, this resulted in a assignment of RoqD and RoqM 
in the biosynthetic pathway. Oxidation of 1 at position C12 – C15 of the histidinyl 
moiety to 2 is carried out by the cytochrome p450 oxidoreductase encoded by roqR 
leading to a previously unknown branch in the pathway. In other studies, 2 was 
reported as a degradation product of 4 under acidic conditions and in-vivo (Scott, 
et al., 1979; Vinokurova, et al., 2001). However, the accumulation of 2 in the ∆roqD 
strain, despite the absence of 4 unequivocally indicates a different origin for the 
production of 2. Two possible reactions of 1 lead to a branch of the roquefortine/
meleagrin pathway, one via oxidation by RoqR to 2 and further to 4 by dimethylallyl 
addition by RoqD, and the other via dimethylallyl addition by RoqD to 3 and further 
to 4 via oxidation carried out by RoqR (Figure 6). 2 is therefore not just a degrada-
tion product of 4 but a true biological product of the roquefortine/meleagrin pa-
thway. The absence of 3 and 4 in the roqD deletion strain and the absence of 2 and 4 
in the roqR deletion strain strongly support our proposal that 2 is the precursor of 4 
following an isoprene addition by RoqD at 2 to form 4, similar to the known reaction 
of 1 to 3 (Figure 6). These observations are very intriguing as they question the pre-
cursor role of 3 to 4 in the proposed roquefortine/meleagrin pathway (Ohmomo, 
et al., 1975). 3 could be the end of the branch leaving 2 as single precursor for 4 if 
RoqD is unable of isoprene addition on 2 to yield 3. Therefore, 2 or 3 or even both 
can be possible precursors of 4. 
Based on the highly significant accumulation of 4 in the roqM deletion strain and 
the absence of all downstream metabolites 5 till 7, we concluded that roqM, en-
coding a MAK 1-monooxygenase like protein, is involved in the conversion of 4 to 
5. This leads to the conclusion that only one enzyme is involved in this prominent 
conversion which combines an oxidation, ring opening and ring closure in one re-
action cascade (Steyn and Vleggaar, 1983). A possible mechanism involves an initial 
hydroxylation at C9 with a subsequent cleavage of the bond between C9 and N14, 
yielding a nine-membered ring with a keto-group at C9. Further oxidation at N1 
of the indole moiety could lead to the loss of water to generate an imine which 
is followed by an attack of N11, ultimately yielding glandicoline A. Maackiain mo-
nooxygenases are known to be responsible for the minor conversion of Maackiain 
to 1-Hydroxymackian by the addition of an oxygen, which differs from the more 
prominent reaction from 4 to 5 found here (Covert, et al., 1996). It should however 
be emphasized that the enzyme assignment was initially based on sequence align-
ment only. Further definition of the mechanism requires an enzymological charac-
terization. 
Our results also demonstrate an involvement of RoqO in the conversion of 5 to 
6. roqO encodes a p450 monooxygenase that oxidizes 5 on its tryptophan moiety, 
resulting in formation of 6. Remarkably, García-Estrada et al. (Garcia-Estrada, et al., 
2011) mixed up the reactions catalyzed by RoqO and RoqM most likely because the 
lower concentrations of 6 were not recognized, whereas 5 could not have been 
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detected at all with the used HPLC-UV approach. Therefore, these authors wrongly 
assigned the biosynthetic pathway leading to the production of 5 by RoqO and 6 
by RoqM. RoqN shares 99 % identity with the UbiE/COQ5 family methyltransferase 
in A. origami. Its activity was confirmed by inactivation of the roqN gene resulting 
in a loss of 7 concomitantly with a 60 times increase of 6. Thus 7 is the methylated 
form of 6, consistent with an involvement of methyltransferase as earlier recogni-
zed (Garcia-Estrada, et al., 2011).
Finally, roqT encodes a highly expressed member of the Multifacilitator Super Fa-
mily of transporters that might be involved in active transport of some of these 
metabolites. However, its deletion had little effect on the metabolic profile sug-
gesting that passive transport, diffusion or another transporter might be involved in 
secretion. It is remarkable that all of the described intermediates are found in the 
extracellular broth which suggests that these compounds effectively diffuse from 
the cell. Alternatively, secretion might be mediated by a relative unspecific export 
system that has not been identified so far. RoqT might fulfill a role in the retention 
of these metabolites (see also below) but this needs to be investigated further in 
feeding experiments.
In order to explore the evolutionary context of this gene cluster among filamentous 
fungi the roquefortine/meleagrin gene clusters in various fungi were compared 
using the antiSMASH algorithm (Medema, et al., 2011). Sorting the gene clusters by 
an empirical similarity score based on the number of BlastP hits between the pre-
dicted proteins of the gene clusters, gene order conservation and the percentage 
identity of the Blast hits resulted in three hits of gene clusters carrying more than 
two homologs of genes from the roquefortine/meleagrin biosynthesis gene cluster. 
One gene cluster, encoded in the genome of Neosartorya fisheria, contained three 
genes closely similar to genes of the P. chrysogenum roquefortine/meleagrin bio-
synthetic pathway (59, 67 and 60 % identity with roqA, roqD and roqO, respectively) 
(Figure 1A, Table S2). This suggests that N. fisheria may be capable of synthesizing 
compounds similar to 1, 2, 3 and 4, using similar biosynthetic mechanisms. A. fu-
migatus and A. terreus also have three genes in common with the P. chrysogenum 
roquefortine gene cluster (roqA, roqD and roqO). Metabolites produced by these 
organisms are likely similar to 1 and 3. However, the final structures may be diffe-
rent as for instance A. fumigatus contains at least four additional genes (annotated 
as phytanoyl-CoA dioxygenase, cytochrome P450, O-methyltransferase and cyto-
chrome P450 monooxygenase) that might be involved in further modifications of 
these secondary metabolites (Table S2).
A time scale study for the production of roquefortine/meleagrin biosynthesis pa-
thway intermediates and products showed an accumulation of 7 in the fermen-
tation broth over time. After 192 hours of growth the metabolite concentrations 
reached their maximum before it declined due to a possible uptake from the media 
or degradation. Uptake of intermediates back into mycelia was previously reported 
for roquefortine (Kulakovskaya, et al., 1997) and it was proposed that these com-
pounds serve as exogenous nitrogen source for colonial expansion (Overy, et al., 
2005). As tryptophan, histidine and mevalonic acid lactone are the building blocks 
of the roquefortine/meleagrin pathway their effect on the production of 1-7 was 
determined in feeding experiments. Although labeling experiments showed the up-




of tryptophan stimulated secondary metabolite formation by this pathway (Figure 
5). This implies that production is limited by the availability of tryptophan provi-
ding a lead for the optimization of roquefortine/meleagrin pathway by metabolic 
engineering of the shikimic acid or anthranilate route for tryptophan biosynthesis 
(Poulsen, et al., 1993). On the other hand, histidine reversed the effect of tryp-
tophan. This might relate to nitrogen-dependent regulation of gene expression as 
roquefortine and related compounds have been implicated as exogenous nitrogen 
sources for colonial expansion (Overy, et al., 2005), and histidine is an excellent 
nitrogen source for P. chrysogenum. Finally, we are currently analyzing additional in-
termediates for structural elucidation. It is most likely that some of the enzymes of 
this pathway lack a certain degree of substrate specificity, which may lead to further 
branching and thus a wider palette of roquefortine/meleagrin related compounds.
Conclusion
Genome sequencing and microarray data analysis revealed seven genes clustered in 
the genome of Penicillium chrysogenum which are highly up regulated in the absen-
ce of the penicillin G precursor phenylacetic acid. These genes are involved in the 
biosynthesis of roquefortine/meleagrin metabolites. Complete deletion of all se-
ven genes and detailed biochemical analysis of respective mutants strains via HPLC, 
MS and NMR revealed that dehydrohistidyltryptophanyldiketopiperazine (DHTD), 
which was previously identified as degradation product, is biologically synthesized 
and a precursor to Roquefortine C. Two enzymes of this pathway catalyze more 
than one reaction i.e. RoqD converts histidyltryptophanyldiketopiperazine (HTD) to 
roquefortine D and DHTD to roquefortine C while RoqR converts HTD to DHTD and 
roquefortine D to roquefortine C. Thus meleagrin is synthesized via a branched pa-
thway rather than a linear biosynthesis.
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Figure S1. Map of the deletion constructs for roqA, roqR, roqD, roqM, roqO, roqN and roqT which were used for 
deletion. Features of the vectors: Amp, Ampicillin resistance gene for the selection in E. coli ; ori, pUC origin of 
replication; attP3, and attP4, Gateway att recombination sites; Pipns, promoter of P. chrysogenum pcbC gene; 















Figure S2. Analytical approach in schematic view. Proteins, present in fermentation broth, were removed during 
sample preparation. Samples were analyzed by HPLC-UV-MS and comparative metabolite profiling performed. Sta-
tistical significant features were extracted using liquid-liquid extraction (LLE) and semi-preparative HPLC-UV-MS 
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C H N O17 17 5 2
+ [M+H] 324.1455
G
C H N O22 25 5 2
+ [M+H] 392.2081
C H N O17 15 5 2
+ [M+H] 322.1299
C H N O22 23 5 2
+ [M+H] 390.1925
C H N O22 21 5 3
+ [M+H] 404.1717
C H N O22 21 5 4
+ [M+H] 420.1666
C H N O23 23 5 4
+ [M+H] 434.1823
Figure S3. HPLC-MS2 fragmentation spectra including chemical formula and calculated exact mass of the protona-
ted HTD (A), DHTD (B), roquefortine D (C), roquefortine C (D), glandicoline A (E), glandicoline B (F) and meleagrin 
(G) acquired at LTQ-FT-MS Ultra at 35% normalized collision energy in positive mode.
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Figure S4. 1H NMR spectrum of DHTD (2).
Figure S5. 1H NMR spectrum of roquefortine D (3). Small additional peaks are not due to impurities but to a second 




Figure S6. 1H NMR spectrum of glandicoline B (6).
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Figure S7. Internal standard corrected metabolite concentration in fermentation broth of P. chrysogenum































































































































Figure S8. Temporal expression of roquefortine/meleagrin biosynthetic gene cluster in P. chrysogenum AFF393 
grown in shaking flask culture.
A branched biosynthetic pathway is involved in production of roquefortine and related 






Table S1. 1H and 13C NMR chemical shifts of DHTD (2), roquefortine D (3) and glandicoline B (6) in DMSO/CDCl3 at 




Table S3. Primers designed for gene expression analysis of roquefortine/meleagrine biosynthetic gene.
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Metabolic profiling and structural elucidation of novel secondary metabolites ob-
tained from derived deletion strains of the filamentous fungus Penicillium chry-
sogenum were used to reassign various previously ascribed synthetase genes of the 
roquefortine/meleagrin pathway to their corresponding products. Next to the struc-
tural characterization of roquefortine F and neoxaline, which are for the first time 
reported for P. chrysogenum, we identified three novel metabolites, namely roque-
fortine L, M and N which harbor remarkable chemical structures. Their biosynthesis 
is discussed, questioning the exclusive role of glandicoline A as key intermediate in 
the pathway. The results reveal that further enzymes of this pathway are rather un-
specific and catalyze more than one reaction leading to excessive branching in the 
pathway with meleagrin and neoxaline as end products of two branches.








The filamentous fungus Penicillium chrysogenum is commercially exploited for 
many decades due to its high production of β-lactam antibiotics like penicillin G 
(Weber, et al., 2012). Next to penicillins, secondary metabolites like roquefortines 
and glandicolines were isolated from liquid cultures of P. chrysogenum which show 
pharmaceutically interesting properties, like neurotoxic (Scott, et al., 1976), anti-
microbial (Clark, et al., 2005; Koolen, et al., 2012) and antitumor (Du, et al., 2010) 
activities. They are structurally closely related and arise from the roquefortine/
meleagrin pathway which contains a di-modular Non-Ribosomal Peptide Synthe-
tase (NRPS) flanked by six associated genes (Ali, et al., 2013; Garcia-Estrada, et al., 
2011). Starting with histidyltryptophanyldiketopiperazine (HTD), synthesized by the 
core synthetase enzyme RoqA using tryptophan and histidine as substrates, RoqD 
catalyzes the reversed prenylation of HTD at the C-3 of its indole moiety utilizing 
dimethylallyldiphosphate to form roquefortine D. At the same time, RoqR, a cyto-
chrome p450 oxidoreductase, oxidizes HTD at its histidinyl moiety to dehydrohisti-
dyltryptophanyldiketo-piperazine (DHTD). Both simultaneous reactions of HTD lead 
to a branch of the roquefortine/meleagrin pathway, one to DHTD via the oxidation 
by RoqR and further to roquefortine C by dimethylallyl addition of RoqD, and the 
other via an alteration of the enzymatic order. There, dimethylallyl addition is first 
performed by RoqD to yield roquefortine D while further oxidation is carried out 
by RoqR yielding roquefortine C (Figure 1). Although several labeling, silencing and 
deletion experiments have been conducted, there is still ambiguity about the sub-
sequent biosynthetic reactions and the genes involved. For instance, roquefortine 
C is supposed to be converted into glandicoline A and further to glandicoline B with 
RoqM and RoqO each catalyzing one reaction (Ali, et al., 2013; Garcia-Estrada, et 
al., 2011). However, their assignment to a particular reaction is still unclear.  In ad-
dition, neoxaline was proposed as final product of the pathway, originating from a 
hydrogenation of meleagrin (Overy, et al., 2005), yet no gene could be found in the 
roq gene cluster performing that reaction.
Here we describe the quantification, structural identification and biosynthesis of five 
previously unidentified metabolites, obtained from high sensitive comparative me-
tabolite profiling of host and deletion strains. Roquefortine F and neoxaline,  next to 
the three structurally novel metabolites, which we named roquefortine L, M and N, 
were found to be derived from the roquefortine/meleagrin pathway. These results 
demonstrate a further branching of this secondary metabolite pathway yielding a 
variety of intermediates with complex structures and a diverse range of activities.
Experimental procedures
Host strains, media, grown condition and plasmid construction
P. chrysogenum strain DS54555, which lacks both the penicillin cluster genes and 
the ku70 gene, was used as a host strain for deletion analysis and was kindly sup-
plied by DSM Anti-infective (Delft, the Netherlands). All the strains were grown on 
YGG-medium for protoplasts formation and transformation. For analysis, cells were 
grown on SMP medium (glucose, 5.0 g/L; lactose, 75 g/L; urea, 4.0 g/L; Na2SO4, 4.0 




lites production using a shaking incubator at 200 rpm for 168 hours at 25°C. 
Metabolite profiling
All strains used for gene assignments were grown in quintuplicate to increase statis-
tical power, according to the procedure described above. Sample preparation was 
carried out as described previously (Ali, et al., 2013). Metabolomic profiling was 
performed on an Agilent 1200 Capillary pump (Agilent, Santa Clara, CA) coupled 
to a Surveyor PDA detector (Thermo Scientific, San Jose, CA) and LTQ-FT-ICR-Ultra 
mass spectrometer (Thermo Scientific, San Jose, CA) equipped with an ElectroSpray 
Interface as described earlier (Ali, et al., 2013).
Metabolite identification
The identity of compound 10 was confirmed by comparing retention time and MS 
fragmentation spectra to its commercially available standard, purchased from Bio-
Connect (Huissen, the Netherlands). Compound 6, 9, 11 and 12 were identified 
using NMR after extraction from liquid cultures. 6 was extracted from the roqN 
deletion strain culture filtrate which was made alkaline with 25 % ammonium hy-
droxide (pH 10) and extracted with dichloromethane. The alkaline dichloromethane 
layer was evaporated to dryness, redissolved in water containing 50 % acetonitrile, 
vortexed, centrifuged and transferred to an autosampler vial for fraction collection 
via preparative reversed phase LC on an Atlantis T3 column (10 x 100mm, 5 µm ) 
(Waters Milford, MA). Compound 9 was extracted following the isolation procedure 
above except using culture filtrate of the roqO deletion strain, while 11 and 12 were 
obtained from the same culture filtrate after lyophilization and extraction using 
methanol. The methanol layer was evaporated to dryness, redissolved in water, 
vortexed, centrifuged and subjected to repeated semi-preparative chromatography 
as described above. Elemental composition of compounds 6, 9, 11 and 12 was de-
termined using high-resolution MS. NMR spectra were recorded on a Bruker Avance 
III 700 MHz or 600 MHz spectrometer with sample temperatures ranging from 260 
K to 300 K, depending on the particular requirements for each sample. By choosing 
an optimal aquisation temperature, severe line broading could be avoided which 
was observed  for various signals due to conformational averaging. For aquisition, 
samples were dissolved in equal amounts of DMSO and CDCl3.
Chemical stability of compound 6
An aqueous solution of compound 6 was adjusted to pH 2.5 by addition of formic 
acid. Metabolite profiling was carried out as described above. Products, formed by 
a degradation of 6, were compared to extracted standards using HPLC-MS/MS.
Results
Metabolite profiling of host and deletion strains leads to five new metabolites of the 
roquefortine/meleagrin pathway
In a previous study, we described the identification of various abundant metabolites 
and resolved the major enzymatic steps belonging to the roquefortine/meleagrin 
pathway (Ali, et al., 2013). In order to identify secondary metabolites originating 
from the roq gene cluster (Figure 1A), culture supernatants of the host strain and 



























































































































































































































































































































































































































































































































































































































































































individually roq gene deletion strains were subjected to comparative metabolite 
profiling using HPLC-UV-MS (Figure 2). As host strain, P. chrysogenum DS54555 was 
used which is derived from the industrial DS17690 strain lacking the ku70 gene and 
multiple penicillin biosynthetic genes clusters. Here, we describe the identification 
and quantification of several less abundant metabolites, roquefortine L (6), roque-
fortine F (9), neoxaline (10), roquefortine M (11) and roquefortine N (12) (Figure 
1B) that have not been previously considered or structurally characterized, filling 
missing biosynthetic reaction steps in the roquefortine/meleagrin pathway. 
























Figure 2. HPLC-MS elution profiles of novel metabolites of the meleagrin/neoxaline pathway. 
HPLC-MS total ion chromatogram (TIC, black) and normalized extracted ion chromatograms (EIC, colored) of novel 
secondary metabolites from the meleagrin/neoxaline pathway. Roquefortine N (12, 15.1 min), roquefortine M (11, 
16.5 min), roquefortine L (6, 16.8 min), neoxaline (10, 17.8 min), and roquefortine F (9, 22.8 min).
Structure elucidation and quantification of 6, 11 and 12
Compound 6 is a novel complex metabolite composed of a roquefortine scaffold and 
a rare nitrone moiety, thus named roquefortine L. The mass-to-charge ratio of its 
corresponding ion was observed at 404.1706 using HPLC-FT-ICR-MS, representing 
the protonated molecule [M+H]+ with formula C22H22N5O3 (calc. 404.1717) eluting 
at 16.5 minutes. The same ion was previously tentatively identified as glandicoline 
A (13) (Figure 1B), as elemental composition and parts of the structure indicated 
consistency with this compound (Ali, et al., 2013). However, its 1H- and 13C-NMR 
data showed high similarity to the diketopiperazine 4, indicating a roquefortine-
like core structure. Furthermore, its 1H-NMR spectrum revealed two protons at C-8 
representing a single bond between C-8 and C-9, which is different from the double 
bond described for 13 (Supplemental Figure 1, Supplemental Table 1).  Additionally, 
C-2 (δC = 146) in the 
13C-HMBC spectrum indicated a double bond between N-1 and 
C-2 which was supported by the chemical shift of N-1 (δN = 280) in the 
15N-HMBC 
spectrum (Supplemental Figure 2, Supplemental Table 1). As compound 13 was re-
ported from various Penicillium species like P. albocoremium (Overy, et al., 2005), 
P. glandicola (Kozlovskii, et al., 1994) and P. chrysogenum (Vinokurova, et al., 2002) 
and proposed as a precursor of 7, host and roq deletion strain chromatograms of 
P. chrysogenum were further analyzed for the presence of 13. The chromatogram 
of the ion with m/z 404.1706, representing the protonated molecular [M+H]+ with 
formula C22H22N5O3 of both compounds 6 and 13, was extracted in a 5 ppm mass 





























































accuracy window. However, no ion possibly corresponding to 13 could be found 
whereas 6 was observed at high concentration in the liquid media (Figure 3). 
Figure 3. Fold change of the concentration of secondary metabolites from the roquefortine/meleagrin pathway 
in deletion strains compared to the host strain. 
Numbers in table represent the internal standard corrected concentrations of secondary metabolites in superna-
tants of deletion strains obtained from HPLC-UV-MS compared to their concentration in the supernatant of the 
host strain P. chrysogenum DS54555. Cell coloring, representing the fold change, was performed on a logarithmic 
scale. Red colored cells indicate a concentration increase whereas green colored cells represent a decrease. Cells 
colored in white indicate a complete absence of the metabolite in the deletion sample. Novel metabolites of the 
roquefortine/meleagrin pathway are shown with bold numbers.
The absence of 13 in host and various P. chrysogenum strains lead to the conclusi-
ons that 13 is not produced by P. chrysogenum DS54555.
Compound 11 and 12 are novel compounds based on a roquefortine-like scaffold, 
thus named roquefortine M and roquefortine N. HR-ESI-MS of 11 (m/z 422.1814 
[M+H]+, calc. 422.1824) and 12 (m/z 440.1918 [M+H]+, calc. 440.1928) established 
the molecular formula C22H23N5O4 and C22H25N5O5. Their chemical structure was de-
termined using 13C-HMBC, 15N-HMBC and 1H-NMR (Supplemental Figure 3 and 4, 
Supplemental Table 2) showing similar signals as observed for compound 6, which 
indicates a similar chemical scaffold. However, the significant upfield shift of N-1 
(from δN = 280 in 6 to δN = 185 in 11) in the 
15N-HMBC spectra together with the 
chemical shift of C-2 (δC = 146 in 6, δC = 172 in 11) in the 
13C-NMR spectra of com-
pound 11 shows that 11 contains a single bond between N-1 and C-2, with C-2 being 
a carbonylic carbon. In addition, a comparison between the 15N-HMBC spectrum 
of compound 11 and 12 revealed that the amide-bond between N-14 and C-13 in 
11 was hydrolyzed in 12 (δN = 32.0) yielding a primary amine and a carboxyl group. 
Both compounds commonly occur, together with compound 6, in liquid cultures of 
P. chrysogenum host and roqT, roqN and roqO deletion strains (Figure 3). Their ab-
sence in the remaining deletion strain samples concludes the involvement of roqA, 
roqR, roqD and roqM in their biosynthesis. 
Structure elucidation and quantification of 9 and 10




420.2015 [M+H]+, calc. 420.2030), was identified as roquefortine F, a metabolite 
solely reported from a deep-ocean sediment derived Penicillium species (Du, et al., 
2009), using 1H- and 13C-NMR (Supplemental Figure 5, Supplemental Table 3). Its 
1H-NMR spectrum is very similar to the spectrum of 3 (Ali, et al., 2013), except 
a double bond between C-12 and C-15. Furthermore, the presence of C-26 (δC = 
63.6) in the 13C-NMR spectrum, next to a sharp OCH3 peak (δH = 4.01) and a mis-
sing proton on N-1 in the 1H-NMR spectrum fully agree with a methoxylated N-1 in 
compound 9. This was supported by the absence of correlations with a carbon or 
proton in the HMBC spectrum. The concentration of 9, particularly high in the host 
strain, was found to be reduced to approximately one third in the deletion strains 
of roqT and roqO and absent in the remaining deletion strains (Figure 3). This data 
suggest that roqO and roqT are the only two genes not involved in the biosynthesis 
of 9. Compound 10 with molecular formula C23H25N5O4 (m/z 436.1967 [M+H]
+, calc. 
436.1979) was identified as neoxaline, a metabolite previously isolated from As-
pergillus japonicas Fg-551 (Hirano, et al., 1979) and P. tulipae (Overy, et al., 2006), 
by comparing retention time and MS/MS fragments to its commercially available 
standard (Supplemental Figure 6). While the concentration of 10 in host and roqT 
deletion strain is almost comparable, a 97% decrease was observed in the roqO 
deletion strain (Figure 3). In all remaining deletion strains, compound 10 could not 
be detected leading to the conclusion that all genes in the roq gene cluster, except 
roqT, are required for the synthesis of 10.
Chemical degradation of compound 6 leads to various products
Nitrones, such as compound 6, are not infinitely stable and degrade already at room 
temperature in aqueous solution as well as under acidic conditions by incorporation 
of water (Cashman, et al., 1999; Rodriguez, et al., 1999; Sun, et al., 2007). In order 
to determine the resulting degradation products, an aqueous solution of 6 was aci-
dified and the resulting sample measured using HPLC-UV-MS (Figure 4). Next to a 
50 % decrease of 6, two highly abundant ions were observed in the treated sample 
corresponding to 11 and 12. Additionally a third unidentified compound was found 
eluting at 17.33 minutes with a mass-to-charge ratio of 422.1823, representing the 
protonated molecule with the formula C22H24N5O4. These results demonstrate that 
11, 12 and an unidentified third compound are produced by degradation of the 
rather unstable compound 6.





Figure 4. Chemical degradation of com-
pound 6 leads to various products. 
Total ion chromatogram of pure (black) 
and degraded compound 6 (blue) af-
ter addition of formic acid measured 
on HPLC-MS. Acid induced degrada-
tion leads to the formation of 11 and 
12 next to an unidentified compound 
eluting at 17.33 minutes with [M+H]+= 
422.1823 and elemental composition 
C22H23N5O4.








Here, we present new insight into the complex biosynthesis of secondary metabo-
lites from the roquefortine/meleagrin pathway. Five novel metabolites were found 
to originate from the roq gene cluster, obtained from comparative metabolites pro-
filing of the host strain and various deletion strains in combination with NMR and 
MS based structure elucidation. As all five metabolites are produced in a late stage 
of the pathway, no changes were observed for the biosynthesis of upstream me-
tabolites 1 – 4, which starts with RoqA taking L-histidine and L-tryptophan as sub-
strates and producing compound 1. Based on the highly significant accumulation 
of 4 in the roqM deletion strain and the absence of all downstream metabolites 
6 – 12 (Figure 3), it can be concluded that roqM, encoding a flavin-dependent MAK 
1-monooxygenase like protein, is involved in the conversion of 4 into 6, a novel 
compound containing an unusual nitrone moiety. Nitrones are widely known due 
to their free radical trapping properties and their potential application as thera-
peutics in age related diseases (Floyd, et al., 2008) like cancer (Floyd, et al., 2011) 
and ischaemic stroke (Maples, et al., 2004). As the chemical scaffold of compound 
6 is closely related to the roquefortine group it was named roquefortine L. Flavin-
containing monooxygenases are commonly known to consecutively oxidize drugs 
and xenobiotics containing a soft-nucleophile, such as nitrogen or sulfur (Krueger 
and Williams, 2005). In case of secondary amines, flavin-containing monooxygena-
ses consecutively oxidize the nitrogen, leading to the production of hydroxylamines 
and nitrones (Cashman, et al., 1999; Rodriguez, et al., 1999; Sun, et al., 2007). A 
similar mechanism for the synthesis of the nitrone containing compound 6 is very 
likely, starting with the oxidation of the secondary amine in the indole part of 4, 


































Figure 5. Proposed biosynthesis of 6 by RoqM.
nitrogen produces an unstable N,N-dihydroxylated species which is followed by the 
loss of water, producing eventually compound 6. However, nitrones are not indefi-
nitely stable and easily degrade at room temperature in aqueous solutions (Cash-
man, et al., 1999; Rodriguez, et al., 1999; Sun, et al., 2007). Under acidic conditions 
compound 6 decomposes by a consecutive incorporation of water leading, among 
others, to the production of compound 11 and 12 (Figure 4 and 6). This decompo-
sition was also observed in NMR experiments after extended storage of a solution 
of 6 at room temperature. These results suggest that the presence of 11 and 12 in 
liquid cultures of P. chrysogenum can be attributed to a chemical degradation of 6. 
Compound 6, with the formula C22H21N5O3, is represented by an ion with a mass-




previously tentatively identified as compound 13 (Ali, et al., 2013) as its elemental 
composition and parts of the structure indicated consistency with this compound. 
However, further structure elucidation using various NMR experiments confirmed 
the structure of 6 instead. This was surprising as compound 13, a proposed key-
intermediate in the biosynthesis of downstream metabolites like 7, 8 and 10 was 
previously tentatively identified in different Penicillium cultures (Overy, et al., 2005; 
Vinokurova, et al., 2002). By using a comparable instrumental set-up with a similar 
chromatographic separation method, host and deletion strains of DS54555 were 
screened for production of 13. Nevertheless, neither 13 nor corresponding degra-
dation products could be detected, whereas 6 was found at high concentrations lea-
ding to the conclusion that 13 is not produced by P. chrysogenum. This is remarka-
ble as 13 was expected as single precursor of 7, modified by RoqO (Garcia-Estrada, 
et al., 2011). In addition, a deletion of roqO resulted in an up to 98 % decrease of 7 
whereas the levels of upstream metabolites remained nearly unchanged, indicating 
that RoqO is indeed involved in the synthesis of 7. Due to the general absence of 
13 in the P. chrysogenum derived samples, compound 7 has to originate from a dif-
ferent biosynthetic route than the previously reported oxidation of 13 on its indole 
nitrogen (Ali, et al., 2013; Garcia-Estrada, et al., 2011; Overy, et al., 2005). RoqO, 
encoding a p450 monooxygenase, closely resembles FtmG (64% identity, 79% si-
milarity at the amino acid level) a cytochrome p450 monooxygenase catalyzing the 
hydroxylation of fumitremorgin C to dihydroxy-fumitremorgin C (Kato, et al., 2009), 
compounds that are structurally similar to the roquefortine derivatives. A possible 
deduced biosynthesis of 7 involves the hydroxylation of 6 on C-9 by RoqO similar 
to the oxidation of fumitremorgin C by FtmG. Subsequent cleavage of the bond 
between C-9 and N-14 followed by the development of a bond between C-2 and 
N-11 is postulated to yield ultimately 7. These results, together with the general 
absence of 13 in P. chrysogenum lead to the conclusion that 7 and 8 are produced 
via a different biosynthesis in P. chrysogenum than in other Penicillium strains like 
P. tulipae (Overy, et al., 2005), for which a tentatively identified 13 was reported as 
intermediate. 
The deletion of roqN resulted in an accumulation of 7 in the liquid medium whereas 
metabolites 8, 9 and 10 were absent (Figure 3). RoqN, a methyltransferase, was pre-
viously recognized to catalyze the addition of a methyl group on the hydroxylated 
nitrogen of 7 producing 8 (Ali, et al., 2013; Garcia-Estrada, et al., 2011). As 9 con-
tains a methylated hydroxylamine group in the same position as 8, the hydroxylami-
ne containing compound 5, which differs only in a methyl-group, is proposed as its 
direct precursor with RoqN catalyzing the methyl addition to yield 9. These results 
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Figure 6. Degradation of 6 yielding 11 and 12 by consecutive incorporation of water.







reveal a further branching of the roquefortine/meleagrin pathway with compounds 
6 and 9 being products of 5. In addition, they support the presence of 5, which was 
proposed based on its involvement in the biosynthesis of 6. 
Compound 10 was previously proposed as direct product of 8 by enzymatic hydro-
genation (Overy, et al., 2005). However, BLAST analysis did not reveal an enzyme in 
the roquefortine/meleagrin pathway, which is able to perform that reaction (Ali, et 
al., 2013; Garcia-Estrada, et al., 2011). Moreover, a 53 times higher concentration 
of 8 compared to 10 in the host strain, but the absence of 8 in the roqO deletion 
strain with 10 still being present, leads to the conclusion that 8 is not a precursor of 
10 (Figure 3). In contrast, due to the high concentration of 9 in the ΔroqO strain and 
its roquefortine-like structure (roquefortine scaffold with a methoxygroup on N-1), 
compound 9 is proposed as direct precursor of 10 with RoqO catalyzing this reac-
tion, similar to the synthesis of 7 from 6. These results suggest that RoqO is involved 
in the reactions from 6 into 7 and from 9 into 10 by oxidizing and subsequently con-
verting a roquefortine scaffold into a glandicoline like structure (Figure 1B).
In conclusion, these results extend the additional branch of compound 9 leading to 
the final product 10. Unspecificity, already observed for RoqR and RoqD (Ali, et al., 
2013), could now also be observed for RoqO and RoqN leading to a complex degree 
of branching in the pathway and a wide palette of compounds. Several of the new 
compounds identified in the current study were found to be equipped with interes-
ting biological activities. Roquefortine F, previously reported from a deep ocean se-
diment derived fungus Penicillium sp., shows moderate cytotoxicity against various 
tumor cell lines (Du, et al., 2009). Neoxaline, which was first isolated from A. japoni-
cas Fg-551, stimulates the central nervous system in mice (Hirano, et al., 1979) and 
inhibits cell proliferation (Koizumi, et al., 2004). Furthermore, it was found to induce 
cell cycle arrest at the G2/M phase in Jurkat cells (inhibition of tubulin polymerizati-
on) (Koizumi, et al., 2004). Here, the novel metabolites roquefortine L, roquefortine 
M and roquefortine N are added to the palette of potential cytotoxic compounds, 
which demonstrates the potential of engineered industrial P. chrysogenum strains 
to produce novel bioactive compounds with unusual chemical scaffolds.
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Supplemental Figure 1. 1H-NMR spectrum of roquefortine L (6) in DMSO/CDCl3 acquired at 300K on a 600 MHz 
spectrometer. Small additional peaks labeled with a star correspond to a second conformation of 6. Assignments 
can be found in Supplemental Table 1.
Supplemental Figure 2. 15N-HMBC spectrum of compound 6 acquired at 290 K. Small additional peaks correspond 





Supplemental Figure 3. 1H-NMR spectrum of roquefortine M (11) acquired at 250 K.
Supplemental Figure 4. 15N-HMBC spectrum of roquefortine M (11) acquired at 270 K.







Supplemental Figure 5. 1H-NMR spectrum of roquefortine F (9) acquired at 280 K.
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Supplemental Figure 6. HPLC-MS/MS fragmentation spectra including chemical formula and calculated exact mass 
of metabolites.  Metabolites shown are protonated compound 6 (roquefortine L, A), 9 (roquefortine F, B), 10 (ne-
oxaline, C), 11 (roquefortine M, D) and 12 (roquefortine N, E). Spectra were acquired at a LTQ-FT-MS at 35% norma-
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The filamentous fungus Penicillium chrysogenum harbors an astonishing variety of 
nonribosomal peptide synthetase genes, which encode proteins known to produce 
complex bioactive metabolites from simple building blocks. Here we report a novel 
non-linear tetra-modular nonribosomal peptide synthetase (NRPS) with a trans-ac-
ting adenylation domain and with a distinctive non-specificity of all involved adeny-
lation domains towards their respective substrates. By deleting the putative gene in 
combination with comparative metabolite profiling various unique cyclic and linear 
tetrapeptides were identified which were associated with this NRPS. In combination 
with substrate predictions for each module, we propose a detailed mechanism of 
the ‘trans-acting’ adenylation domain.
A single unspecific non-linear NRPS is involved in the synthesis







Fungal non-ribosomal peptides contribute a large variety of secondary metaboli-
tes with remarkable properties such as antibacterial, antifungal, antiparasitic, an-
ticancer and immunosuppressive activities. These metabolites are produced by 
large, multifunctional protein complexes, called nonribosomal peptide synthetases 
(NRPS) that catalyze the stepwise condensation of simple amino acid building blocks 
to complex molecules. NRPSs have a modular organization, with each module res-
ponsible for one discrete chain-elongation step. Every single module can be subdivi-
ded into domains that carry all essential information for recognition, activation and 
modification of one substrate. At a minimum, a typical NRPS module consists of an 
adenylation (A) domain, responsible for amino acid activation, a thiolation domain, 
also known as peptidyl carrier protein (PCP), which binds the activated amino acid 
and a condensation (C) domain that catalyzes peptide-bond formation. The com-
mon arrangements of these domains follow a (C-A-PCP)n organization. Additionally, 
a variety of optional domains have been described such as methyltransferase (MT) 
and epimerization (E) domains (Schwarzer and Marahiel, 2003).
The number of modules and their domain organization within NRPS enzymes con-
trols the structures of the final product(s) (Grunewald and Marahiel, 2006; Mootz 
et al., 2002; Schwarzer et al., 2003). Thus, the order of modules usually corresponds 
to the sequence of amino acids in the peptide. Many NRPS systems adhere to this 
mechanistic paradigm, which is often referred to as the “co-linearity rule” (Fisch-
bach and Walsh, 2006). Also exceptions to this rule have been discovered, including 
iterative NRPSs, which incorporate multiple residues of the same amino acid itera-
tively into the peptide structure and the so called nonlinear NRPSs, which deviate 
completely from the standard domain organization leading to unexpected products 
(Mootz et al., 2002; Shaw-Reid et al., 1999).
The impact of non-ribosomal peptide metabolites on the quality of human life rai-
sed the interest of pharmaceutical industries to invest in identification, engineering 
and heterologous expression of NRPS genes and pathways to ensure the rational 
production of novel compounds (Stevens et al., 2006; Wyatt et al., 2012; Zhang et 
al., 2013). To understand the basic mechanisms of the biosynthesis of these com-
plex NRPSs, detailed studies have been performed during the past few decades. 
These included the structural analysis of adenylation domains, mutational analysis 
of substrate specificity of these modules, the fusion of unrelated modules to pro-
duce new products and the identification of helper proteins for optimal activation 
of adenylation domains (Baltz, 2011; Conti et al., 1997; Doekel et al., 2008). Alt-
hough this has led to detailed insights into catalytic mechanisms, so far a structure 
of a complete NRPS is lacking that would reveal how modules cooperate to facilitate 
product formation. The availability of genome sequencing data and sophisticated 
bioinformatics analysis of various fungi revealed the presence of many NRPS genes 
that have not been associated with known secondary metabolites (Khaldi et al., 
2010; Pel et al., 2007; van den Berg et al., 2008). Moreover, most of these genes are 
not expressed when the fungi are grown under laboratory conditions, implying that 
many more secondary metabolites await discovery.
The filamentous fungus Penicillium chrysogenum is well known for the production 




aminoadipyl)-L-cysteinyl-D-valine synthetase. In addition, other NRPS derived se-
condary metabolites like the roquefortine toxins and meleagrin have been reported 
  3: cyclo-(Tyr-Trp-Val-Val) 
  4: cyclo-(Phe-Trp-Val-Val)
  5: cyclo-(Phe-Phe-Val-Ile)
  6: cyclo-(Phe-Phe-Ile-Val)
  7: cyclo-(Tyr-Trp-Val-Ile)
  8: cyclo-(Tyr-Trp-Ile-Val)



















1: cyclo-(D-Phe-L-Phe-D-Val-L-Val) 2: cyclo-(D-Tyr-L-Phe-D-Val-L-Val)
fungisporin
Figure 1. Identified secondary metabolites 
Structures of cyclic tetrapeptides identified in P. chrysogenum.
from P. chrysogenum (Ali et al., 2013; Frisvad et al., 2004; Garcia-Estrada et al., 
2011). Here, we describe the identification and structural characterization of cyclic 
tetrapeptides (Figure 1) and the discovery of a tetra-modular NRPS with an unusual 
domain organization and limited specificity of its adenylation domains. It is propo-
sed to term this NRPS PcHcpA based on the produced Hydrophobic cyclic peptides.
Experimental procedures
Chemicals
AQC reagent and borate buffer were obtained as part of AccQ Tag Reagent Kit from 
Waters (Waters, Milford, MA, USA). cyclo-(d-Tyr-l-Phe-d-Val-l-Val) was obtained 
from Celtek Peptides (Nashville, TN).
Host strains, media, grown condition and plasmid construction
Deletion of the PcHcpA gene was carried out in P. chrysogenum strain DS54555, 
which lacks penicillin cluster genes and the Ku70 gene (Ali et al., 2013). This strain 
was kindly provided by the DSM Biotechnology Center (Delft, Netherlands). Dele-
tion plasmids were constructed by amplifying the flanking regions of the targeted 
gene with the Multisite Gateway®Three-Fragment Vector Construction Kit (Invitro-
gen). Escherichia coli (DH5α) was used as host strain for high frequency transfor-
mation and plasmid DNA amplification (Sambrook et al., 1989). All the strains were 
grown on YGG-medium for protoplasts formation and transformation (Kovalchuk 
et al., 2012). Both mutant and host strains of P. chrysogenum were grown on SMP 
medium as described previously (Ali et al., 2013).
Transformation procedure
Deletion plasmids were transformed to the protoplasts of P. chrysogenum DS54555 
(Alvarez et al., 1987). The phleomycin resistance gene was used as selection marker 
for the deletion of the PcHcpA gene (Kolar et al., 1988; Kovalchuk et al., 2012). 
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Genomic DNA extraction, total RNA extraction, cDNA amplification and qPCR ana-
lysis
Genomic DNA (gDNA) was isolated after 96 hours of growth on SMP medium using 
the modified yeast gDNA isolation protocol (Harju et al., 2004) in which the fun-
gal mycelium is broken in a FastPrep FP120 system (Qbiogene). Isolated gDNA was 
measured using a NanoDrop ND-1000. gDNA of the host and various deletion strains 
was isolated using the E.Z.N.A. Fungal DNA kit (Omega Bio-tek). Total RNA of the 
host strain was isolated after 48 hours of growth in SMP medium for the first time 
and then with the interval of 24 hours up to 216 hours of growth using the Trizol 
reagent (Invitrogen), with additional DNase treatment using the Turbo DNA-free kit 
(Ambion). Total RNA was measured with the NanoDrop ND-1000 and a concentra-
tion of 500 ng per cDNA reaction was used. cDNA was synthesized using the iScript 
cDNA synthesis kit (Bio-Rad) in a 10 μl end volume. The primers used to analyze 
the expression of the PcHcpA gene were designed around an intron to avoid ampli-
fication on gDNA (Table S3). For expression analyses, the γ-actin gene was used as 
a control for normalization. A negative reverse transcriptase (RT) control was used 
to determine the gDNA contamination in isolated total RNA. The expression levels 
were determined as described (Ali et al., 2013).
Southern blotting
Southern blotting was carried out by digesting gDNA (5 μg) with the indicated res-
triction enzymes. Digested DNA fragments were separated on a 0.8 % agarose gel, 
blotted onto a Zeta-Probe membrane (Biorad) as described earlier (Nijland et al., 
2008), and hybridized with the indicated DIG labeled probes.
Metabolite profiling
Host and deletion strains of P. chrysogenum strains used for gene assignments were 
grown in quintuplicate according to the procedure described above. Samples for ac-
quisition of the metabolite profiles from the growth curves were from five replica-
tes. Metabolite profiling was carried out with modifications as described earlier (Ali 
et al., 2013). Briefly, 4 µl of internal standard mixture (855 nmol/mL ranitidine, 657 
nmol/mL reserpine and 114 nmol/mL ampicillin) was added to 100 µl fermentation 
broth followed by the addition of 400 µl methanol for protein precipitation. The 
samples were vortexed and spun down at 14,000 g for 10 minutes. 300 µL superna-
tant was evaporated for 30 minutes in a speedvac (Thermo Scientific, San Jose, CA) 
and re-dissolved in 100 µL water. LC-UV-MS analysis was performed on an Agilent 
1200 Capillary pump (Agilent, Santa Clara, CA) coupled in-line to a Surveyor PDA 
detector (Thermo Scientific, San Jose, CA) and LTQ-FT mass spectrometer (Thermo 
Scientific, San Jose, CA) using electrospray ionization and operated in a scan range 
between m/z 110 and m/z 2000 in positive/negative ion switching mode. Separa-
tion was performed on a Waters Atlantis T3 column (2.1 x 100 mm, 3 µm) (Waters, 
Milford, MA) starting with 98 % of solvent A (1 % acetonitrile and 0.1 % formic acid 
in water) and 2 % solvent B (1 % water and 0.1 % formic acid in acetonitrile) for 1.5 
minutes at a flow rate of 300 µL/min. 40 % B were reached after 22 minutes and 
100 % B at 25 minutes. The column was flushed with 100 % B and re-equilibrated to 




tool followed by statistical tests to discover significant different features. Finally, 
discovered features were integrated using LCquan v.26 (Thermo Scientific, San Jose, 
CA). The non-related non-endogenous compound reserpine was used as internal 
standard.
Identification of cyclic tetrapeptides
The identity of cyclic tetrapeptides was determined using samples from liquid cul-
tures of P. chrysogenum and a crude precipitate containing primarily 1 and 2 next to 
various minor abundant cyclic tetrapeptides. LC-MSn experiments for the determi-
nation of consecutive amino acid losses were performed according the metabolite 
profiling section with normalized collision energies of 35 %, an isolation width of 
m/z 1 and an activation Q of 0.30. NMR spectra were recorded on a Bruker Avance 
III 700 MHz NMR spectrometer (Bruker, Billerica, MA), equipped with a 5 mm TCI 
probe. 2 mg of each sample was dissolved in 0.6 mL anhydrous DMSO. NMR spectra 
were acquired at 340 K.
Identification of linear tetrapeptides
Linear tetrapeptides were identified according their multiple-stage fragmentation 
after AQC derivatization (Noga et al., 2012). Methanol (400 µL) was added to an ali-
quot of 100 µL fermentation broth for protein precipitation. Samples were vortexed 
for 10 minutes, spun down for 10 minutes and 300 µL of the supernatant was eva-
porated to dryness in a speedvac (Thermo Scientific, San Jose, CA). Derivatization 
was done according to the supplier’s procedure by re-dissolving the sample in 40 
µL water, 40 µL borate buffer (pH 8.5) and 20 µL AQC solution. The mixture was 
vortexed for 10 minutes and heated for 10 minutes at 55°C. 
LC-MSn experiments were conducted on an Agilent 1200 Capillary pump (Agilent, 
Santa Clara, CA) coupled to a LTQ-FT mass spectrometer (Thermo Scientific, San 
Jose, CA) using electrospray ionization. Separation was performed on a Waters At-
lantis T3 column (2.1 x 100 mm, 3 µm) (Waters, Milford, MA) starting with 72 % of 
solvent A (1 % acetonitrile and 0.1 % formic acid in water) and 28 % of solvent B (1 
% water and 0.1 % formic acid in acetonitrile) for 1.5 minutes at a flow rate of 300 
µL/min. After 8 minutes the gradient reached 60 % of solvent B. Subsequently, the 
column was flushed with 100 % B before it was re-equilibrated to initial conditi-
ons. The peptide sequences were elucidated using multiple-stage collision-induced 
dissociation (CID) of the protonated molecule following consecutive cleavages of 
amino acids residues, starting from the C-terminus of the derivatized linear tetra-
peptide. CID was performed with normalized collision energies of 35 %, an isolation 
width of m/z 1 and an activation Q of 0.30.
Results
Bioinformatic analysis of a tetrapeptide NRPS  
Genome sequencing revealed that P. chrysogenum encodes 11 NRPS genes (van den 
Berg et al., 2008). Microarray expression analysis under glucose-limited chemostat 
culture conditions as well as quantitative PCR under shake flask culture condition 
showed that Pc16g04690 (PcHcpA) is highly expressed (Figure 2A) (van den Berg et 
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al., 2008). The PcHcpA gene encodes a large multimodular non-ribosomal peptide 
synthetase enzyme (Figure 3) with 6064 amino acids and a calculated molecular 
mass of about 670 kDa. PcHcpA, which shows 54% sequence identity to the ortho-
logous An08g02310 (AnHcpA) in A. niger, has the domain architecture A1-PCP1-E-
C2-A4-A2-PCP2-C3-A3-PCP3-E-C4-PCP4-C-PCP (A = adenylation, C = condensation, PCP = 
thiolation, and E = epimerization) (Figure 3A) (van den Berg et al., 2008). A similar 
domain architecture was deduced for the orthologous AnHcpA protein of A. niger 
except for an insertion of a 177 amino acid long sequence between the adenylation 
domain A4 and A2 which shows homology to conserved motifs of an incomplete 
condensation domain (Co) (Figure 3A). To predict the substrate specificity of the four 
adenylation domains of PcHcpA and AnHcpA, NRPSPredictor2 was used (Rottig et 
al., 2011). This program extracted the active site amino acid motifs DAACVAGVAK 
as the signature sequence for the A1 domain in PcHcpA and DAVIIAAVAK in AnHcpA, 
which have similarity with the signature sequence of the adenylation domain of a 
bacitracine-producing NRPS that activates phenylalanine as a substrate. The sig-
nature sequences for the A4 domain (DAVSAGVAAK in PcHcpA and DMQSAWFICK 
in AnHcpA) shows homology with the valine-activating adenylation domain of the 






















































gramicidin synthetase, whereas the A2 (DAMTVGGVFK for PcHcpA and DVLSTGAICK 
for AnHcpA) and A3 (DAMFVGGVFK for PcHcpA and DAMFVGGIFK for AnHcpA) do-
mains have predicted specificities towards phenylalanine and valine, respectively. 
The overall architecture of both synthetases is unusual, as the A2 and A4 domains 
occur adjacent to each other, flanked by a single C and PCP domain in a C2-A4-A2-
PCP2 pattern. On the other hand, an incomplete module (C4-PCP4) without an adja-
cent A domain is found at the N-termini of these NRPSs (Figure 3A).
Genetic deletion of the tetrapeptide NRPS and secondary metabolite identification
In order to identify the secondary metabolites synthetized by PcHcpA, the corres-
ponding gene was deleted and comparative metabolite profiling was performed on 
the culture supernatant of the host and deletion strain. As host strain, P. chrysoge-
num DS54555 was used, which is derived from the industrial DS17690 strain, and 
that lacks the ku70 gene to make it competent for homologous recombination. The 
Figure 2. Correlation between the expression level of PcHcpA and metabolite formation
A: Time dependent expression level of PcHcpA as determined by quantitative RT-PCR.
B: Internal standard corrected concentration of the cyclic peptide 1 and its degradation products 11-13 present in 
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Figure 3. Model for the biosynthesis of compound 1 in P. chrysogenum and A. niger by the HcpA NRPS.
A: Binding of the monomers on the carrier protein domains. Both isolated condensation and thiolation domains C4 
and T4, missing a preceding adenylation domain, are assumed to correspond to the adenylation domain A4, located 
upstream. 
B: Proposed assembly of compound 1 including condensation domains presumed for catalyzing the formation of 
the peptide bond. 
DS54555 strain also lacks the multiple penicillin biosynthetic genes clusters in order 
to facilitate the detection of unknown secondary metabolites in the culture broth 
as the profile is no longer dominated by β-lactams. PcHcpA was deleted by homolo-
gous recombination using the deletion plasmid pDEST R4-R3p (Figure S1) containing 
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the flanking regions of PcHcpA and the phleomycin resistance gene. Colonies were 
selected on phleomycin containing agar plates where the mutant colonies showed 
smooth phenotypic characteristics compared to the wrinkled surface of the colo-
nies of the parental strain (Figure 4). The deletion of the PcHcpA gene was confir-
med by southern blot hybridization (Figure 5A). 
The host and ∆PcHcpA strain were grown for 168 hours in secondary metabolite 
production medium (SMP Medium) followed by comparative metabolite analysis 
using HPLC-UV-MS. Several secondary metabolites were found to be present in the 
host but absent in the deletion strain (Figure 6, Table S1). These compounds could 
be classified into two groups according their chemical structure. The first group con-
sists of ten cyclic tetrapeptides, which were identified using HPLC-MSn, NMR and 
a synthetic standard (Figure 1). Upon excitation, cyclic tetrapeptides undergo ring 
opening in the mass spectrometer resulting in four linear tetrapeptides which can 
be sequenced in a similar fashion as linear peptides. By following the sequential 
loss of amino acids from b-ions of each generated linear tetrapeptide, the sequence 
of their cyclic origin could be determined (Figure S2). The identities of the involved 
amino acids, corresponding to the losses in the mass spectrometer, as well as their 
sequence were additionally confirmed by 1H-NMR and 13C-NMR experiments for 
the compounds 1 and 2 (Table S2 and S3). To discriminate the amino acid isoleucine 
from its isomer leucine, which is represented by a loss of 113 Da (C6H11ON) in the 
mass spectra of compounds 5-10, 1H-, 13C- and various 2D-NMR experiments were 
conducted (Figure S3, Table S4). Overall, cyclic tetrapeptides obtained from meta-
bolic profiling contain various combinations of the five amino acids valine, isoleu-
cine, phenylalanine, tyrosine and tryptophan making them extremely hydrophobic. 
They are arranged in a common sequence in which two aromatic amino acids are 
followed by two aliphatic amino acids. The absolute stereochemistry of compound 
2 was confirmed by spiking its synthetic standard to a natural extract which did not 
lead to additional signals in the 1H-NMR spectra, whereas the intensity of the main 
signals increased as compared to the impurities (Figure S4A and B). In addition, su-
perimposing the HMBC spectra of the natural and the synthetic sample of peptide 
2 illustrated identical correlations and shifts (Figure S5).  Furthermore, retention 
time and MS2 fragmentation did not show differences between the extracted com-
pounds and their synthesized standards. This leads to the conclusion that not only 
Figure 4. Colonies of P. chrysogenum strain DS54555




the sequence of amino acids is identical in the synthetic and natural peptide, but 
also the chirality of the individual amino acids. Therefore, the cyclic tetrapeptide 2 
has the same stereochemistry as observed for 1 (Studer, 1969) with the first amino 
acid of an aliphatic and aromatic pair in D- and the second amino acid in L-form. 
The second category of identified compounds consists of 18 linear tetrapeptides 
which are comprised of the same five amino acids as their cyclic analogues (Table S1 
and S5).  Similar to the cyclic peptides, each linear tetrapeptide contains two alip-
hatic and two aromatic amino acids in different arrangements yielding various iso-
meric structures. Due to similar chromatographic properties and an identical mass-
over-charge ratio, these isomers are represented as a group in data obtained from 
metabolic profiling (Figure S6A and B). Their structure elucidation is challenging as 
minor fragments can be attributed to a fragmentation of low abundant linear tetra-
peptides as well as to possible sequence scrambling of major linear tetrapeptides 
which was reported for similar linear peptides (Bleiholder et al., 2008). To sepa-
rate and sequence these isomeric tetrapeptides and to prevent possible sequence 
scrambling, their N-terminus was derivatized using 6-aminoquinolyl-N-hydroxysuc-
cinimidyl carbamate (AQC) (Figure S6C and D) (Cohen and Michaud, 1993). De novo 


































Figure 5. Southern blot analysis for PcHcpA deletion 
and concentration of cyclic tetrapeptides in culture 
broth of host strain
A: Southern blot hybridization validating the com-
plete gene deletion of PcHcpA.
B: Internal standard corrected concentrations of 
the cyclic tetrapeptides 1-10 present in the culture 
broth of the host strain of P. chrysogenum grown 
for 168 hours. Isomers are presented together as no 
chromatographic separation was obtained during 
profiling. No cyclic tetrapeptides could be found in 
the deletion strain.
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peptide sequencing was performed by following the consecutive amino acid losses 
of various b-ions using multiple-stage fragmentation mass spectrometry (Figure S6E 
and Table S5). Similar to the cyclic peptides, each linear tetrapeptide incorporates 
two consecutive aromatic and/or two consecutive aliphatic amino acids. 
In conclusion, several linear and cyclic tetrapeptides with similar structural features 
were found to be present in the host but absent in the deletion strain which shows 
that they originate from one single NRPS, namely PcHcpA.
Expression of the PcHcpA gene and secondary metabolite production
To examine the expression of the PcHcpA gene, the host strain was grown for up to 
216 hours in secondary SMP medium. Samples were collected for total mRNA ex-
traction and extracellular metabolites analysis during growth. Metabolite concen-
trations were determined by HPLC-UV-MS, while transcript levels were determined 
by quantitative PCR using γ-actin as a reference gene. A high expression level of 
the PcHcpA gene was observed between 120 and 168 hours of growth, which was 
paralleled by a 12 times increase in the concentration of cyclic tetrapeptide 1 (Fi-
gure 2A and B) in the medium. In general, the concentration of cyclic tetrapeptides 
was exceptionally high around 168 hours of growth, while the concentration of the 
linear tetrapeptides increased with time. These data suggest that the linear tetra-
peptides are derived from the cyclic tetrapeptides by degradation. 
Discussion
Here we have demonstrated that the NRPS PcHcpA is responsible for the biosyn-
thesis of cyclic hydrophobic tetrapeptides. Bioinformatics analysis of PcHcpA shows 
an unusual domain architecture in comparison to classical linear NRPSs with no 
products associated so far. However, through the deletion of the PcHcpA gene and 
comparative metabolite profiling, ten cyclic tetrapeptides were identified, including 
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Figure 6. HPLC-MS elution profiles of the internal standard reserpine and the highest abundant identified peptides 
Total ion chromatogram (TIC, black) and normalized extracted ion chromatograms (EIC, colored) of the protonated 
molecule ([M+H]+ with 5 ppm accuracy) of the used internal standard reserpine (A), the four highest abundant 
cyclic tetrapeptides 1 (B), 2 (C), 3 (D), 4 (E) and linear tetrapeptides 11-13 (F), 14-16 (G), 17-19 (H), 20-22 (I) present 




the previously described secondary metabolite fungisporin 1 (Studer, 1969). Accor-
ding to the non-ribosomal code in combination with discovered cyclic products, 
the first NRPS module is specific for phenylalanine. Due to the adjacent E domain, 
responsible for epimerization of the activated amino acid, a D-configuration is ex-
pected as observed for product 1 (Figure 1). The next two modules of the NRPS con-
tain an unusual architecture in which PCP2 and C3 are flanked by two neighboring 
adenylation domains A2 and A4. As adenylation domain A4 shows high specificity 
towards valine and adenylation domain A2 shows high homology towards A1, both 
adenylation domains activate phenylalanine as supported by the structure of 1. Due 
to the lack of an adjacent PCP domain for A4 and a missing C domain for A2, which 
are necessary for loading and condensation of the substrate, no module activity is 
expected according the classical C-A-PCP geometry (Figure 3A). Surprisingly, both 
products 1 and 2 show the incorporation of L-phenylalanine at the second position. 
As module 2 is predicted to be the only module capable to catalyze the incorpora-
tion of L-phenylalanine, A2 indeed must be active. Consequently, it seems likely that 
A4 is skipped, leaving the N-terminal C2 domain of module 2 to catalyze the conden-
sation of the first amino acid from module 1 to the second amino acid from module 
2, as observed for the products 1 and 2. The third module of PcHcpA contains the 
domains C3, A3, PCP3 and E arranged in a common linear order. The A3 domain is 
predicted to activate valine which agrees with the peptide sequence of 1 and 2, as 
D-valine is their third amino acid. The fourth module of the NRPS is an incomplete 
module consisting of C4 and PCP4. Due to a missing preceding A domain no activity 
is expected. However, the chemical structures of both cyclic tetrapeptides 1 and 2 
show the incorporation of L-valine as fourth amino acid in their peptide sequence. 
As A4 is the only domain predicted to be specific to valine without an adjacent epi-
merization domain, it is very likely that this domain is a ‘trans-acting’ A domain that 
interacts with C4 and PCP4 to add the last amino acid to the tetrapeptide. A similar 
architectural flexibility has been observed in the biosynthesis of yersiniabactin, in 
which one A domain, located in HMWP2, loads three PCPs located on different mo-
dules (Gehring et al., 1998a; Gehring et al., 1998b; Suo et al., 2001).  As the linear 
domain organization of PcHcpA does not reflect a linear assembly of substrate in-
corporation into the final product, non-linear interactions are deduced. Although 
A4, C4 and PCP4 are not in a consecutive sequence on a genomic level, they might 
still be closely arranged in the final three-dimensional enzymatic structure. Struc-
tural characterization would be necessary to determine spatial proximity. Finally, 
after the incorporation of L-valine into the peptide chain, the C and PCP domain 
of the last module catalyze the cyclization of the peptide leading to the final cyclic 
structure, as previously observed in other NRPS systems (Gao et al., 2012; Keating 
et al., 2001).
Next to the production of 1 and 2, eight additional lower abundant cyclic tetrapepti-
des were identified to be present in the host strain and absent in the deletion strain 
(Figure 1). They show a similar peptide sequence as 1, containing two aromatic 
amino acids followed by two aliphatic amino acids. Although stereochemical infor-
mation is only available for the compounds 1 and 2, it can be assumed that each 
of the cyclic tetrapeptides contains an aliphatic and aromatic amino acid in the D 
configuration, more specifically at the first and third position. These assumptions in 
combination with the stereochemical structure of 1 and 2 lead to the conclusion, 
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that each adenylation domain of PcHcpA shows specificity towards more than one 
precursor amino acid with A1 being specific towards phenylalanine and tyrosine and 
A2 being specific towards phenylalanine and to a lesser extent to tryptophan (Table 
S6). Together with the two aliphatic amino acid selecting adenylation domains A3 
and A4, which preferably activate valine before isoleucine, 16 cyclic tetrapeptide 
combinations are theoretically possible. However, only ten of these were detected 
in the fermentation broth of P. chrysogenum confirming a different degree of spe-
cificity towards their precursors. Based on a similar chemical scaffold of identified 
compounds 1-10 to the tetrapeptides cyclo-(N-MePhe-Ile)2, cyclo-(N-MePhe-Val)2 
and cyclo-(N-MePhe-val-N-MePhe-Ile) reported from Onychocola sclerotic, cardiac 
channel blocking activities can be expected for the hydrophobic cyclic peptides pre-
sented here (Perez-Victoria et al., 2012). In addition, the colonies of the ΔPcHcpA 
strain lost the ability to produce a wrinkled surface leading to a rather smooth ap-
pearance (Figure 4). As this change is attributed to the deletion of the PcHcpA gene, 
the hydrophobic cyclic peptides 1-10 need to be involved. Possibly, these molecules 
function analogous to hydrophobins in altering the surface properties and influen-
cing aerial growth. The exact function is, however, still unclear.
Next to cyclic tetrapeptides several highly abundant linear tetrapeptides could be 
observed in the cultural broth of the host strain that were absent in the deletion 
strain. To each of the cyclic tetrapeptides, several linear tetrapeptides with the 
same sequence were present. For instance, in addition to the cyclic tetrapeptide 
1 with the sequence cyclo-(Phe-Phe-Val-Val), three linear tetrapeptides with the 
sequences Phe-Val-Val-Phe, Val-Phe-Phe-Val and Phe-Phe-Val-Val could be found at 
different ratios. Their concentration increased over time in the media while their cy-
clic counterpart decreased after 168 hours (Figure 2B). This leads to the conclusion 
that the linear peptides originate from the degradation of their cyclic counterparts 
by hydrolysis of their peptide bonds, which was observed exclusively between two 
aromatic, two aliphatic or an aliphatic followed by an aromatic amino acid (Table S1 
and S5). Linear tetrapeptides with a N-terminal aliphatic amino acid and a C-termi-
nal aromatic amino acid were not detected, leading to the conclusion that cleavage 
of this bond is not favorable. As cyclic tetrapeptides are relatively stable towards 
chemical and thermal degradation, enzymatic hydrolysis might be most probable.  
 
PcHcpA shows 54% amino acid sequence identity with its orthologous AnHcpA from 
A. niger with exactly the same module organization (Figure 3A). Furthermore, all 
cyclic products 1-10 present in P. chrysogenum could also be found in the superna-
tant of an A. niger strain while they were absent in the AnHcpA deletion strain (un-
published data). Therefore, it is concluded that AnHcpA is involved in production of 
all cyclic metabolites (1-10) in A. niger. A small difference exists in the organization 
of the PcHcpA and AnHcpA proteins with a short additional amino acid sequence 
present between domains A4 and A2 in AnHcpA. This sequence showed limited ho-
mology to a condensation domain and appears as an incomplete condensation do-
main. Hence, one may deduce that this noncanonical situation might have evolved 
quite recently. Perhaps, a complete C-A-PCP-C-A-PCP module structure was present 
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Deletion plasmid used for deleting HcpA in P. chrysogenum
Supplementary Table 1.
Retention time, formula and acquired m/z of cyclic and linear tetrapeptides obtained from metabolic profiling. 
Isomers have the same retention time as they could not be chromatographically separated during profiling.
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Supplementary Figure 2. Multiple-stage fragmentation for de novo sequencing of compound 2 based on sequential 
amino acid losses
A: MS2 fragmentation spectra of the cyclic tetrapeptide 2 cyclo-(d-Tyr-l-Phe-d-Val-l-Val). Due to ring opening of the 
cyclic peptide in the mass spectrometer at different positions, three different amino acid losses occurred, yielding 
different b3-ions. 
B-D: MS3 fragmentation spectra obtained by further fragmenting b3-ions from MS
2 showing b2-ions used for peptide 
sequencing. 
The cyclic tetrapeptides 1 and 3-10 were identified accordingly.
Supplementary Table 2.
1H and 13C-NMR chemical shifts of syn-
thetically produced compound 2 with 
sequence cyclo-(d-Tyr-l-Phe-d-Val-l-Val) 
in DMSO at 340 K. As synthetically and 
naturally produced 2 show identical 
NMR spectra, only chemical shifts for 
the synthetically produced compound 
are shown. δDMSO (






1H and 13C chemical shifts of naturally produced compound 1 with sequence cyclo-(d-Phe-l-Phe-d-Val-l-Val) present 
in a mix of various cyclic tetrapeptides in DMSO acquired at 340 K. Signals overlapping with the highest abundant 
compound 2 are indicated (*). δDMSO (1H/13C) = (2.55/40.50), (δ in ppm).
Supplementary Figure 3. 
HSQC spectrum of isolated mix of cyclic tetrapeptides in DMSO used for the identification of isoleucine present in 
the minor abundant products 5 and 9. Signals corresponding to isoleucine are indicated with circles. Conducted 
TOCSY, COSY and HMBC experiments further confirm this conclusion (data not shown). 1H and 13C chemical shifts 
are shown in Supplementary Table 4.
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1H and 13C chemical shifts of isoleucine in compound 5 with sequence cyclo-(Phe-Phe-Val-Ile) and compound 9 with 
sequence cyclo-(Phe-Phe-Val-Ile) present in a extracted mix of cyclic tetrapeptides. NMR signals corresponding to 
















A: 1H-NMR spectrum of a precipitate of various cyclic tetrapeptides containing primarily peptide 1 and 2 (bottom). 
Synthetic compound 2 spiked to the precipitated mix of various cyclic tetrapeptides in DMSO at 340 K (top). Signals 
corresponding to 2 were increased as compared to the impurities whereas additional signals did not appear.
B: Zoomed regions of 1H-NMR spectrum of natural precipitate (bottom) and precipitate spiked with compound 2 




Supplementary Figure 5. 
Superimposed HMBC spectra of synthetic compound 2 (red) and an isolated mix of cyclic tetrapeptides containing 
naturally produced compound 2 (black). Correlations between NH and CO are shown which indicate identical shifts 
for both samples. Assignments can be found in Supplementary Table 2.
Supplementary Table 5. 
Sequencing data leading to the identification of linear tetrapeptides after AQC derivatization. Multiple-stage frag-
mentation was used for determination of b-ions for de-novo peptide sequencing.
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Supplementary Figure 6. Sequencing of the linear isomers 11 (Phe-Phe-Val-Val), 12 (Val-Phe-Phe-Val) and 13 (Phe-
Val-Val-Phe). 
A: Extracted ion chromatogram (EIC) of the linear tetrapeptides 11, 12 and 13 using the profiling method. No chro-
matographic separation could be achieved.
B: MS2 fragmentation spectrum of unseparated linear tetrapeptides 11-13. Although the spectrum is dominated by 
fragments originating from 11, several lower abundant fragments can be found originating from a fragmentation of 
12 and 13 or possible sequence scrambling of 11. 
C: Sequence of linear tetrapeptides after N-terminal AQC derivatization to achieve better chromatographic separa-
tion and to prevent sequence scrambling.
D: Normalized total ion chromatogram (TIC) of AQC derivatized linear peptides 11-13 after first C-terminal amino 
acid loss showing chromatographic separation and allowing peptide sequencing.
E: Individual MS3 fragmentation spectra of chromatographically separated derivatized peptides 11, 12 and 13 sho-
wing b2 and b1 ions used for peptide sequencing.





Identified and proposed cyclic and linear tetrapeptides in respect to the adenylation domain specificity in the NRPS 
PcHcpA.
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Towards automated de novo structure elucidation using 
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Chemoinformatics supported MSn Comparison Pipeline (CMCP): Towards automated de novo 
structure elucidation using multiple-stage fragmentation tree comparison





Here we present a novel multiple stage fragmentation tree based structure eluci-
dation pipeline for the de novo structure identification of small molecules, coined 
CMCP (Chemoinformatics supported MSn Comparison Pipeline) which combines 
sample extraction, fragmentation tree acquisition, database screening and data in-
terpretation. Based on high-resolution multiple-stage fragmentation mass spectra 
(MSn), fragment and neutral-loss trees are generated and compared to a MSn data-
base to extract compounds with similar fragmentation behavior. By identifying their 
shared fragmentation mechanisms, chemical structures of unknowns can be dedu-
ced without them needing to be present in the database. As the structure elucida-
tion presented here is based on structural identification of similar fragments and 
neutral-losses rather than solely their comparison, confident identification of un-
known molecular structures is possible beyond classifications into compound clas-
ses. Most important conceptual outcomes of a database query using fragment and 
the newly introduced neutral-loss tree comparison are discussed showing how this 
information can ultimately be used to deduce complete chemical (sub)structures 
of unknown compounds. For their demonstration, the de novo identification of the 
complex metabolites roquefortine C, dehydrohistidyltryptophanyldiketopiperazine 
(DHTD), roquefortine F and roquefortine D extracted from cultures of Penicillium 
chrysogenum is described in detail. 







With the prevalent application of metabolomics, several methods and techniques 
for the simultaneous analysis of a large number of metabolites have been develo-
ped which provide detailed information about the metabolome of complex biolo-
gical samples. However, their structural identification, necessary to describe and 
interpret cellular processes, is still a major bottleneck in metabolomics (Kind and 
Fiehn, 2006). 
Mass spectrometry (MS) in combination with chromatographic separation tech-
niques is widely used for the analysis of metabolites due to its high sensitivity, 
low demand on sample purity and rapid analysis time (Villas-Boas, et al., 2005). 
Especially liquid chromatography MS (LC-MS), which is increasingly used in recent 
years, allows to analyze relative polar and thermally unstable compounds without 
prior derivatization. Different types of MS instruments are available to fragment 
ionized molecules and detect their charged fragments providing structural informa-
tion. Using these instruments, several MS/MS databases and software tools have 
been generated in order to facilitate metabolite identification (Horai, et al., 2010; 
Wishart, et al., 2009). However, most approaches are limited to identity searches, 
in which the unknown compound needs to be present in the database or to the 
assignment of unknowns into compound classes based on similar fragmentation 
(Rasche, et al., 2012; Sheldon, et al., 2009). This leaves the complete structure elu-
cidation of unknowns still a major challenge. 
Compared to MS/MS approaches in which fragments can be immediately fragmen-
ted further after generation, MSn methods provide a more detailed fragmentation 
pathway. As only precursor ions are exited, fragments cool after formation, thus 
avoiding further fragmentation giving deeper insight into relationships between 
fragments (Stein, 2012). With the use of such a multidimensional mass spectrome-
try approach spectral trees can be generated containing precursor-product ion rela-
tionships (Sheldon, et al., 2009). Based on correlations between specific fragments 
in the MSn spectra and the substructure of the measured molecule, structural elu-
cidation of unknown compounds can be performed (Chen, et al., 2002; Fandino, et 
al., 2002; Wang, et al., 1999). However, as extensive databases and software tools 
are  scarce, MSn data handling and interpretation is mainly still limited to the ma-
nual identification of characteristic fragments from defined classes of compounds 
(Cui, et al., 1999; Kang, et al., 2007; Rochfort, et al., 2008), leaving the full power of 
multiple stage fragmentation mass spectra untapped. As a consequence our group 
recently extended the MEF (mass elemental formula) tool (Rojas-Cherto, et al., 
2011; Rojas-Cherto, et al., 2012) for processing and comparing MSn data which ex-
tracts ion-signals from MSn spectra, followed by assignment of their corresponding 
elemental composition. 
In previous work, the functionality of the MEF tool has been demonstrated for the 
determination of similarities between database entries (Rojas-Cherto, et al., 2012) 




ver, the conserved structural information of the analyte, reflected by specific frag-
mentation mechanisms and the chemical structure of fragments and neutral-losses, 
was not exploited. 
Here, we present a chemoinformatics guided pipeline for the structural identifi-
cation of unknown compounds coined CMCP (Chemoinformatics supported MSn 
Comparison Pipeline). By combining small scale sample extraction, fragmentation 
tree acquisition and the extended MEF tool with MS expert knowledge, the chemi-
cal structure of low concentrated complex molecules can be identified using solely 
mass spectrometry (Figure 1). We discuss the most important conceptual outcomes 
of a database query using CMCP and demonstrate how this information can ulti-
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Figure 1. Schematic view of the CMCP pipeline for the identification of unknown compounds in a biological sample 
and structures of identified compounds 1 – 4.
Experimental procedures
Strain and culture conditions
Penicillium chrysogenum strain DS54555, which lacks the Ku70 and penicillin clus-
ter genes was supplied by DSM Anti-infective (Delft, The Netherlands). Cells were 
grown on SMP medium (glucose, 5.0 g/L; lactose, 75 g/L; urea, 4.0 g/L; Na2SO4, 4.0 
g/L; CH3COONH4, 5.0 g/L; K2HPO4, 2.12 g/L; KH2PO4, 5.1 g/L) using a shaking incuba-
tor at 200 rpm for 168 hours at 25°C.
Small scale isolation of analytes 
Low amounts of the four structurally complex metabolites 1 – 4 (Figure 1), were ex-






tracted from liquid cultures of P. chrysogenum using the LC-UV-MS method descri-
bed elsewhere (Ali, et al., 2013). Briefly, 230 µL of methanol was added to 50 µL of 
P. chrysogenum culture filtrate for protein precipitation. The sample was vortexed, 
centrifuged and 100 µL supernatant transferred to an Eppendorf vial which was sub-
sequently evaporated in a Thermo-Speedvac (Thermo Scientific, San Jose, CA). The 
dried sample was re-dissolved in 100 µL water containing 2 % acetonitrile, vortexed 
and transferred to an autosampler vial. For separation, an Agilent 1200 Capillary 
pump (Agilent, Santa Clara, CA) coupled to a Surveyor PDA detector (Thermo Scien-
tific, San Jose, CA) and LTQ-FT Ultra mass spectrometer (Thermo Scientific, San Jose, 
CA) was used. A sample of 5 µL was injected onto a Waters Atlantis T3 column (2.1 
x 100 mm, 3 µm) (Waters, Milford, MA). The elution was performed with a linear 
gradient from 98 % of solvent A (1 % acetonitrile and 0.1 % formic acid in water) and 
2 % solvent B (1 % water and 0.1 % formic acid in acetonitrile) to 100 % of Solvent 
B in total of 25 minutes (first 1.5 minutes isocratic at 98% A, then to 40% of solvent 
B at 22 minutes and 10% solvent B at 25 minutes) at a flow rate of 300 µL/min. The 
column was flushed for 10 minutes at 100% B followed by equilibration for 8 minu-
tes at 100 % A. Fractions of 1, 2, 3 and 4 were collected manually and subsequently 
evaporated to dryness in a Speedvac.
Preparation of Working Solutions
Working solutions were prepared by re-dissolving the dried fraction of each meta-
bolite in 20 µL water containing 50% acetonitrile and 0.1% formic acid. Right before 
acquisition, working solutions were mixed with 5 µL isopropanol in a 384 well plate 
to increase nano-electrospray stability (Eppendorf, Hamburg, Germany).
Fragmentation tree acquisition, processing and database comparison
Fragmentation tree acquisition was carried out on a LTQ-Orbitrap-XL mass spec-
trometer (Thermo Fisher Scientific, Waltham, MA) equipped with an Advion Nano-
mate nano-electrospray source (Advion, Ithaca, NY) (1,5 kV source voltage, 120°C 
capillary temperature, 5 V capillary voltage, 70 V tube lens voltage and 35 % nor-
malized collision energy for CID fragmentation) according a modified protocol des-
cribed elsewhere (Kasper, et al., 2012). The scan rate of the mass spectrometer was 
set to 6 micro scans. At least three complete fragmentation trees were acquired per 
compound.
The ten most abundant fragment ions in MS2, the nine highest in MS3 and three 
highest in MS4 were isolated and further fragmented resulting in 371 (1 MS2, 10 
MS3, 90 MS4 and 270 MS5) possible fragmentations. Isolation width was set to 1.5 
m/z and minimal precursor intensity required for further fragmentation was fixed to 
50.000 counts. Acquired Thermo Xcalibur files were converted into mzXML format 
using ReadW software (Pedrioli, et al., 2004). Chemical formulas were assigned to 
all fragments of the acquired tree using the MEF tool (Rojas-Cherto, et al., 2011). 
MEF processing parameters were as following: Signal-to-noise ratio 1, mass accura-
cy 10 without applying the nitrogen rule or degree of unsaturation (Pellegrin, 1983). 
Finally, all processed trees were compared to an in-house metabolite MSn database, 
containing more than different 400 entries, to find similar fragments and neutral-





Fragmentation tree generation and similarity search 
To demonstrate the different conceptual outcomes of a database query and to show 
how this information can be used to deduce structural information, the de novo 
identification of the four unknown metabolites roquefortine C (1), dehydrohistidyl-
tryptophanyldiketopiperazine (DHTD) (2), roquefortine F (3) and roquefortine D (4) 
is described in detail (Figure 1). Compounds 1 - 4 were obtained, next to six additio-
nal compounds, from comparative metabolite profiling of host and various deletion 
strains of P. chrysogenum, using high resolution mass spectrometry (HPLC-HR-MS) 
(Ali, et al., 2013). Their mass was determined as 390.192 (1), 322.129 (2), 420.203 
(3) and 392.208 (4) dalton, corresponding to the protonated molecules with for-
mula C22H24N5O2, C17H16N5O2, C23H26N5O3 and C22H26N5O2. As none of the ions had 
a corresponding entry in a public MS database like MassBank (Horai, et al., 2010), 
HMDB (Wishart, et al., 2009) or PRIMe (Akiyama, et al., 2008; Sakurai, et al., 2013) 
and because the biosynthetic mechanism of their producing gene cluster was not 
known, additional structural information was not available leaving their structure 
completely unknown. In order to acquire multiple stage fragmentation mass spec-
tra, small scale fraction collection was performed to extract low amounts of pure 
analytes from P. chrysogenum culture broth. Subsequently, fragmentation trees 
were acquired and processed according the description in the method section. The 
resulting fragment and neutral-loss trees were compared to an in-house metabolite 
MSn database, which was searched for similar mass fragments and neutral-losses 
present in database entries. Database entries were ranked according their degree 
of similarity, represented by the Tanimoto coefficient (Flower, 1998), yielding the 
database entry of protonated roquefortine C with formula C22H24N5O2 as most simi-
lar compound to all four metabolites.
Structure elucidation based on identical fragment and neutral-loss trees
With the precursor and almost all fragments and neutral-losses of 1 being present 
and similarly arranged as in the fragment and neutral-loss tree of roquefortine C, 
an identical chemical structure of 1 and roquefortine C was indicated (Figure 2). 
This was supported by a comparison of their multiple stage fragmentation spectra 
which showed fragments with almost identical mass-over-charge ratios and rela-
tive intensities over multiple fragmentation stages (data not shown). Based on the 
known structure of the database entry, the structure of 1 was tentatively assigned 
as roquefortine C which was ultimately confirmed using HPLC-MS/MS comparing 
the retention time of 1 and a roquefortine C standard
Structure elucidation based on similar fragment and neutral-loss trees
For compound 2, the database query returned partial similarity to its most simi-
lar database entry roquefortine C with almost all fragments and neutral-losses of 
compound 2 present and similarly arranged as in the database entry (Figure 3, Sup-
plemental Figure 1 and 2). However, compared to the identification of compound 
1, in which compound 1 and the database entry showed the same ion in MS1, here 
different ions were observed, respectively m/z 322 (ID 1, MS1, C17H16N5O2) in com-
pound 2 and m/z 390 (ID 1, MS1, C22H24N5O2) in roquefortine C.
























































































































































































































































































































Figure 2. Fragment tree  of compound 1 after comparison to the fragment tree of the most similar database entry 
roquefortine C. Fragments present in both compounds are colored according their position in a shared fragmenta-
tion path. For the visualization of similarities overlapping nodes present in both fragment trees are colored, unique 
ions present only in one tree are white. Different colors indicate the length of the largest path of consecutive 
fragments that two fragment trees have in common. A comprehensive description of the fragmentation tree repre-
sentation was published earlier (Rojas-Cherto, et al., 2012).
For further structure elucidation, the two highly similar subtrees of fragment m/z 
322 (ID 28, MS2, C17H16N5O2) in roquefortine C and m/z 322 (ID 1, MS
1, C17H16N5O2) 
in compound 2 were used. Their similarly arranged fragments and neutral-losses, 
containing an identical elemental composition, indicated that the fragment with 
m/z 322 originating from the precursor ion m/z 390 (ID 1, MS1, C22H24N5O2) in ro-
quefortine C has an identical structure as the ion m/z 322 of 2, which represents the 
protonated molecule in MS1. This was further supported by comparing the multiple 
stage fragmentation spectra of their common subtrees which showed fragments 
with almost identical mass-over-charge ratios and relative intensity over multiple 
fragmentation stages (Figure 4). By identifying the chemical structure of the frag-
ment m/z 322 in roquefortine C, formed by a loss of isoprene, and transferring the 
information to 2, the structure of protonated 2 could be determined as dehydro-
histidyltryptophanyldiketopiperazine (DHTD) (Figure 5). Its tentative structure was 
ultimately confirmed by NMR experiments (Ali, et al., 2013). 
An example in which the fragmentation tree of a database entry is a complete sub-
tree of an unknown compound is the identification of compound 3, which shares a 
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ion m/z 390 (ID 1, MS1, C22H24N5O2) in roquefortine C and m/z 390 (ID 100, MS
2, 
C22H24N5O2) in 3 (Supplemental Figure 3 and 4). As the complete tree of roquefortine 
C is present in the tree of 3, including the precursor ion in MS1, an identical structure 
for the ion m/z 390 in both compounds is concluded. This is supported by identical 
fragmentation spectra over multiple fragmentation stages initiated by a fragmen-
tation of the ions at m/z 390 in both compounds (Supplemental figure 5). Compa-
red to roquefortine C, compound 3 contains one additional carbon, two additional 
hydrogens and one additional oxygen which were cleaved off during first fragmen-
tation yielding ion m/z 390 (ID 100, MS2, C22H24N5O2) with an identical structure as 
protonated roquefortine C. Supported by the competing losses of CH3O• and CH4O 
from a fragmentation of m/z 420 (ID 1, MS1, C23H26N5O3) yielding the fragments m/z 
389 (ID 46, MS2, C22H23N5O2) and m/z 388 (ID 29, MS
2, C22H22N5O2), the structure of 
the loss producing m/z 390 could be determined as formaldehyde originating from 
the cleavage of a methoxygroup (Stevigny, et al., 2004). Therefore, a roquefortine 
C structure is concluded for compound 3 with a methoxygroup attached. Its posi-
tion in the structure of 3 is unclear, as the methoxygroup is cleaved off in the first 





































































Figure 4. MS2 fragmentation spectrum of compound 2 (A) and MS3 fragmentation spectrum of the database entry 





































m/z 322 C17H16N5O2 m/z 322 C17H16N5O2


















Figure 5. Proposed fragmentation mechanism of database entry roquefortine C yielding compound 2 in situ in the 
mass spectrometer.  After an initial protonation, the bond between C2 and N14 is cleaved in roquefortine C fol-
lowed by a 1,4-hydride shift leading to the loss of isoprene, yielding m/z 322.
Chapter 5
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pound 4 (left) and roquefortine C (right) show
ing highly sim
ilar neutral-loss cascades present in both trees. The shared neutral-loss 
path used for the identification of 4 is show
n in the m
iddel in m
ore detail. Detailed neutral-loss trees of roquefortine C and 4 obtained from
 neutral-loss tree com
parison can be 
found in the supplem
ent.






fragmentation stage. Using NMR experiments, the structure of 3 was determined as 
roquefortine F, containing the structure of roquefortine C with a methoxygroup on 
the nitrogen in the indol part of the molecule which is in good agreement with the 
results obtained from CMCP (Chapter 3).
It should be pointed out that although the protonated form of 2 and roquefortine 
C share the identical ion m/z 322, their subtrees differ significantly in depth and 
width. Therefore, not all fragments of m/z 322 (ID1, MS1) in 2 could be found in the 
subtree of m/z 322 (ID28, MS2) in roquefortine C. This is due to the fact that next 
to different observed absolute intensities of the ions, two ions originating from dif-
ferent fragmentation stages are compared. While for 2, ion m/z 322 was found in 
MS1, for roquefortine C it was found in MS2. Due to the limitations of the acquisition 
protocol, the further fragmentation of an ion in MS1 can result in maximal 371 frag-
mentations (1 MS2, 10 MS3, 90 MS4, 270 MS5) whereas the further fragmentation 
for an ion in MS2 is limited to maximal 37 fragmentations (1 MS3, 9 MS4, 27 MS5). As 
a consequence, a much richer fragmentation tree was acquired for the ion m/z 322 
in compound 2. Similar results were obtained for the identical ion m/z 390 present 
in MS1 of roquefortine C and MS2 in 3 for which a much a richer fragmentation was 
observed in roquefortine C.
Structure elucidation based on similar neutral-loss cascades
For compound 4, the database query returned partial similarity to its most similar 
database entry roquefortine C, showing similar neutral-loss cascades over various 
fragmentation stages with only few shared unconnected fragments (Figure 6, Figure 
7, Supplemental Figure 6 and 7). For further structure identification, the neutral-loss 
cascade C5H8 – C9H7N – C3H3NO2 shared by roquefortine C (ID 28, ID 62, ID 66) and 
compound 4 (ID 20, ID 107, ID 108) was used. As this relative specific neutral-loss 
cascade is shared by both compounds, it can be concluded that 4 might have similar 





































































Figure 4. MS2 fragmentation spectrum of compound 2 (A) and MS3 fragmentation spectrum of the database entry 




structural features as roquefortine C, resulting in similar fragmentation mechanisms 
with similar neutral-losses upon excitation. Identifying these common fragmenta-
tion mechanisms, based on the known structure of the database entry, resulted in a 
partial identification of 4, containing a dimethylallyl (C5H8), indol (C9H7N) and diketo-
piperazine (C3H3NO2) moiety similarly arranged (Figure 8). Striking is to see that the 
difference in the elemental composition between both compounds, two additional 
hydrogens in the structure of 4, are conserved throughout the entire fragmentation 
process and still being present in the final fragment with m/z 110 (ID 108, MS4, 
C5H8N3). Although the structure of corresponding fragment of roquefortine C can 
be deduced based on the known structure of roquefortine C, structural informa-
tion about the final fragment of 4 is not available, as a further fragmentation was 
not successful. However, in combination with gene deletion experiments (Ali, et al., 
2013), concluding that compounds 1 – 4 originate from the same biosynthetic gene 
cluster, the structure of 4 was tentatively identified as roquefortine D which was 












a: m/z 390 C22H24N5O2












a: m/z 322 C17H16N5O2










a: m/z 193 C8H9N4O2











a: m/z 108 C5H6N3
b: m/z 110 C5H8N3






Figure 8. Proposed fragmentation of database entry roquefortine C (a) and compound 4 (b).  After protonation, 
isoprene, represented by the loss of C5H8, is cleaved off in the first fragmentation step yielding the fragment m/z 
322 in roquefortine C and m/z 324 for compound 4. Due to the subsequent loss of the indole part of the structure, 
indicated by a loss of C9H7N, ions m/z 193 in roquefortine C and m/z 195 in 4 are formed. In the final fragmentation 
step the ring of the diketopiperazine structure opens, leading to a loss of C3H3NO2 and the formation of m/z 108 in 
roquefortine C and m/z 110 in 4.
Discussion
The results presented here demonstrate how the metabolite identification pipeline 
CMCP can be used to obtain detailed structural information of structurally com-
plex molecules. Using fragment and neutral-loss tree comparison, structural simi-
lar compounds were extracted from a MSn database. As structural information is 
coded in the fragments, neutral-losses and fragmentation mechanisms, structural 
similarities between the unknown compound and the database entry are revealed. 
Identifying these shared mechanisms, linked to substructure information stored in 
the database or using MS expert knowledge, and applying them to the unknown 
molecule allows complete (sub)structures identification even without the unknown 
being present in the database, as shown for the de novo identification of com-
pounds 2 - 4. 
Depending on the structural overlap between the analyte and a database entry, 
high similarity can be a result of similar fragments, similar neutral-losses or a com-
bination of both. Particularly the comparison of neutral loss trees, which is used 
here for the first time to obtain detailed structural information, represents a valu-






able structure elucidation approach as it uses complementary information to frag-
ment trees for the determination of similarity. As almost no fragments are shared 
between the database entry roquefortine C and compound 4, a comparison solely 
based on similar fragments would not have been as successful. However, it should 
be pointed out that there can be a large gap between the degree of similarity ob-
tained from fragment tree comparison and neutral-loss tree comparison. This is due 
to the fact that similarity based on fragments can be verified as fragments can be 
further fragmented generating a fragmentation subtree which contains structural 
information about the particular fragment. In case the obtained multiple stage frag-
mentation spectra are identical, it can be assumed that their precursor possess an 
identical chemical structure. In contrast, loss tree comparison is based exclusively 
on uncharged neutral-losses which can, by definition, not further be fragmented. 
Although their structures can be deduced from the known structure of the data-
base entry and applied to the unknown analyte, as shown for the identification of 
compound 4, it is not possible to absolutely confirm the identical identity of shared 
losses in both compounds. Certainty that the exact same losses with the same frag-
mentation mechanisms occur in both compounds is depending on the length of 
the shared loss path and the uniqueness of the losses. The loss path C5H8 – C9H7N 
– C3H3NO2 used for the identification of 4 contains relatively unique fragments cor-
responding to dimethylallyl, tryptophan and diketopiperazine substructures which 
are only shared with the database entry roquefortine C.
Uncovering relationships between neutral-losses and providing extensive structural 
information about individual fragments by further fragmenting them, is the main 
advantage of MSn methods compared to MS/MS techniques, as it offers crucial in-
formation beyond elemental compositions and intensities. However, the structu-
ral information conserved in the fragments also needs to be exploited. Especially 
for smaller databases which do not provide enough positive hits to determine the 
structure of a fragment or neutral-loss solely on the structural overlap of a common 
substructure of multiple similar database entries, fragments and losses need to be 
manually assigned to a particular part of the molecule. Without using this structural 
information, the identification of 2 - 4 would have been limited to a structural clas-
sification resulting in a somehow relationship to roquefortine C. With the advent 
of novel software tools for the processing of multiple stage fragmentation data, 
tandem mass spectra databases may be replaced by MSn databases due to the ad-
ditional structural information available within.
Traditionally, the number of analytes which can be identified using mass spectro-
metry depends on the comprehensiveness of the database, as identity searches 
require each analyte to be represented by an identical database entry. Thus, large 
databases with numerous entries are necessary to cover a large chemical space. 
By searching for fragmentation similarities between multiple stage fragmentation 
trees as presented here, rather than complete identities, less comprehensive da-
tabases are required. For the identification of compounds 1 – 4, only one database 
entry was necessary to represent the fragmentation of a specific structural group 
of compounds, as shown for roquefortine C which was used to identify the meta-
bolites 1 – 4.
In addition, CMCP paves the way towards a fully automated structure identification 




of fragments and neutral-losses into the MSn database, detailed structural infor-
mation of nodes in database entries is extended. Using this information, structures 
of similar nodes present in the unknown target compound can be automatically 
assignment enabling an immediate identification of fragments and neutral-losses 
without much intervention of MS experts. By automatically combining the struc-
tural overlap of various subtrees or losses even from different similar database en-




Here, we present a structure elucidation pipeline that allows the complete struc-
tural identification of unknown molecules beyond structural classification without 
the need of the compound to be present in the database. It could be shown that 
fragment and neutral-loss tree comparison yield complementary information which 
makes neutral-loss tree comparison a valuable addition for the identification of un-
knowns. In combination with the ongoing structural identification of fragments and 
neutral-losses, automatic substructure assignment is possible, paving the way for a 
completely automated structure elucidation.
Concluding, fragmentation tree comparison is an important component of our me-
tabolite identification pipeline which combines comparative metabolite profiling 
and structure elucidation using CMCP and NMR analysis. With this pipeline various 
(novel) metabolites of P. chrysogenum were identified and their biosynthesis could 
be determined. Future work on direct-infusion experiments and data processing 
tools aim to improve the throughput of this pipeline by overcoming the relative 
resource-intensive small scale extraction of the unknown compounds.
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Supplemental Figure 1. Fragment tree of compound 2 compared  to the fragment tree of database entry roquefor-
tine C as indicated by colored nodes.

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Figure 4. Fragment tree of the database entry roquefortine C compared to the fragment tree of 
compound 3. 









































































Supplemental Figure 5. MS3 fragmentation spectrum of compound 3 (A) and MS2 fragmentation spectrum of the 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Figure 6. Neural-loss tree of compound 4 compared to the neutral-loss tree of the database entry 
roquefortine C. 





















































































































































































































































































































































































































































































































































































































Multiple stage fragmentation tree comparison
enables detailed structure elucidation in direct infusion mass 
spectrometry based experiments 
Based on
Marco I. Ries, Hazrat Ali, Arnold J.M. Driessen, Thomas Hankemeier, Theo Reijmers, Rob J. Vreeken
Multiple stage fragmentation tree comparison enables detailed structure elucidation in direct 
infusion mass spectrometry based experiments 





Direct infusion mass spectrometry (DI-MS) is a fast, reliable, sensitive and cost ef-
fective method which is particularly attractive when dealing with large sample sets. 
However, structure identification in direct infusion based experiments is still a ma-
jor obstacle due to co-fragmenting interferences like isobaric and isomeric ions, li-
miting most applications to metabolite fingerprinting only. 
Here we present the application of CMCP (Chemoinformatics supported MSn Com-
parison Pipeline) for the identification of metabolites in direct infusion based expe-
riments. We demonstrate the structure elucidation of secondary metabolites in a 
complex liquid culture of Penicillium chrysogenum using multiple stage fragmenta-
tion spectra from single precursor ions as well as with isobaric and isomeric interfe-
rences. Next to the structure elucidation with the sample compound being present 
in the database, structure identification based on similar structures is described 
enabling de novo structure elucidation in direct infusion based experiment beyond 
a classification of compounds into compound classes. 
This study presents a potential method to identify unknown metabolites conve-
niently in DI, without additional instrumental configurations, extending DI to more 
than just a first line approach.
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 







With the prevalent application of metabolomics, several methods and techniques 
for the simultaneous analysis of a large number of compounds have been develo-
ped which provide detailed information about the metabolome of complex biologi-
cal samples. Traditional approaches for the determination of metabolites by mass 
spectrometry use chromatographic separation like GC (Gas Chromatography), LC 
(Liquid Chromatography) or CE (Capillary Electrophoresis) before metabolite detec-
tion, thus generating qualitative or quantitative information on individual analytes 
(Dettmer, et al., 2007). These methods require laborious and time consuming sam-
ple preparation procedures and significant analysis time due to chromatographic 
separation. Furthermore, separation and detection of metabolites is heavily depen-
ding on the chemical nature of the analytes and the used chromatographic method. 
In general, a combination of various analytical techniques like HILIC, RP or Ion-pai-
ring, targeting different classes of metabolites, is necessary as no single analytical 
platform allows a comprehensive analysis of the metabolome.
An alternative high-throughput approach to capture information related to the total 
metabolite content is the use of direct infusion mass spectrometry (DI-MS) (Boern-
sen, et al., 2005; Goodacre, et al., 2002; Koulman, et al., 2007) which renounces 
the limiting separation step before sample ionization, allowing the fast detection of 
various metabolite classes. During the ionization process of electrospray ionization 
(ESI), the most common method used for ionization in mass spectrometry based 
experiments, analytes become charged by the loss or gain of a proton, or other ad-
ducts. As minimal fragmentation takes place during ionization, the measured mass 
of an analyte, recorded with high mass accuracy and resolution, is expected to be 
close to the anticipated mass of a specific metabolite recorded in a database, po-
tentially allowing a direct putative identification (Mungur, et al., 2005; Nakamura, et 
al., 2007; Raterink, et al., 2013). Several databases containing metabolite informa-
tion are available in order to facilitate putative annotation of accurate mass signals 
(e.g. PubChem (Li, et al., 2010), HMDB (Wishart, et al., 2009), KEGG (Kanehisa, et al., 
2012), KNapSAcK (Afendi, et al., 2012)). However, an accurate mass does not give 
any structural information beyond the molecular formula, limiting most direct infu-
sion experiments to screening purposes only (Draper, et al., 2013). Using MS/MS, 
individual precursor ions can be selected and fragmented, resulting in specific frag-
ment ions which can help to elucidate the structure of the molecule. The interpreta-
tion of MS/MS experiments is challenging as isobaric ions (same nominal mass) and 
isomeric ions (same chemical composition) are fragmented simultaneously, resul-
ting in MS2 spectra with mixed fragments of various precursor ions (Wichitnithad, 
et al., 2010). Although newer generation mass spectrometers substantially reduce 
co-fragmentations with isolation widths as narrow as 0.5 m/z (mass-to-charge ra-
tio) (Savitski, et al., 2011), co-fragmentation of interferences can’t be completely 
avoided leaving structure identification in direct infusion a major challenge. There-




cidation involving chromatographic separation and MS or NMR based approaches 
which in return, compromise the advantages of DI experiments. Especially finding 
back the target molecules, obtained from DI screening, in chromatographic based 
experiments is challenging as the physiochemical properties of the targeted analyte 
are mostly unknown. 
In contrast to MS/MS approaches, multiple stage mass spectrometry (MSn) enables 
a further fragmentation of fragments generating so called fragmentation trees. As 
solely selected ions are further fragmented, insight into multidimensional precur-
sor-parent ion relationships is obtained. With the chemical structure of the precur-
sor coded in its fragments and neutral-losses, structural information of the precur-
sor ion can be deduced (Cui, et al., 1999; Kang, et al., 2007; Rochfort, et al., 2008). 
Recently, our group developed CMCP for the structure elucidation of compounds 
using solely multiple stage fragmentation tree comparison (Chapter 5). By compa-
ring fragment and neutral-loss trees, compounds with similar fragmentation me-
chanisms can be extracted from a MSn database (Kasper, et al., 2012; Rojas-Cherto, 
et al., 2012). Based on the identified shared fragmentation mechanisms, chemical 
structures of unknowns can be deduced without them being present in a database.
Here we show the enormous potential of CMCP for the structure elucidation of 
compounds from complex analyte mixtures using direct infusion. To demonstrate 
the capabilities of our approach to identify compounds from fragmentation data of 
one population of structurally identical precursors as well as from co-fragmented 
isobaric and isomeric ions, the structure elucidation of various complex metabolites 




ne (2) was purchased from Sigma-Aldrich.
Preparation of working and stock solutions of 1 and 2
Stock solutions consist of 1 µg/mL analyte in ethanol. A working solution was pre-
pared by mixing the stock solutions of compound 1 and 2 in a 1:5 ratio. Right before 
acquisition 10 µL working solution was mixed with 5 µL isopropanol and 10 µL water 
containing 0.1 % formic acid in a 384 well plate (Eppendorf, Hamburg, Germany).
Strain and culture conditions
P. chrysogenum strain DS54555, which lacks the Ku70 and penicillin cluster genes 
was kindly supplied by DSM Anti-infective (Delft, The Netherlands). Cells were 
grown on SMP medium (glucose, 5.0 g/L; lactose, 75 g/L; urea, 4.0 g/L; Na2SO4, 4.0 
g/L; CH3COONH4, 5.0 g/L; K2HPO4, 2.12 g/L; KH2PO4, 5.1 g/L) using a shaking incuba-
tor at 200 rpm for 168 hours at 25°C.
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 







To 50 µL of a thawed fermentation broth 8 µL internal standard mixture containing 
855 nmol/mL ranitidine, 657 nmol/mL reserpine and 1144 nmol/mL ampicillin was 
added. Subsequently, 230 µL of methanol was added for protein precipitation and 
vortexed for 10 minutes. The sample was then centrifuged at 14,000 g for 10 mi-
nutes at 10°C. 100 µL supernatant was transferred to an Eppendorf vial and evapo-
rated for 30 minutes in a Thermo-Speedvac (Thermo Scientific, San Jose, CA). The 
dried sample was resolved in 100 µL water containing 2 % acetonitrile and vortexed 
for 10 minutes.
Fragmentation tree acquisition, processing and database comparison
Fragmentation tree acquisition was carried out as previously described (Chapter 5) 
in positive ion mode on a LTQ-Orbitrap-XL mass spectrometer (Thermo Fisher Scien-
tific, Waltham, MA) using an Advion Nanomate (Advion, Ithaca, NY) for nano-elec-
trospray with following settings: 1,5kV source voltage, 120°C capillary temperature, 
5V capillary voltage, 70V tube lens voltage and 35 % normalized collision energy for 
CID fragmentation. A minimum of three repetitions of the complete fragmentation 
tree were acquired.
Assigned fragmentation trees were created from acquired Thermo Xcalibur files 
using a macro programmed in Excel (Microsoft, Redmond, WA). Finally, all proces-
sed trees were compared to an in-house fungal metabolite MSn database for deter-
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Figure 1. Structures of discussed compounds
Results and Discussion
To demonstrate the capability of CMCP to confidently elucidate the identity of 
unknown compounds in DI based experiments despite a co-fragmentation of in-
terferences, the structure identification of the four analytes roquefortine C (1, 
C22H23N5O2, calc. [M+H]
+ = 390.1924), 3-me-7-(3-methylbenzyl)-8-((1-phenylethyl)
amino)-3,7-dihydro-1H-purine-2,6-dione (2, C22H23N5O2, calc. [M+H]
+ = 390.1924) , 
glandicoline B (3, C22H21N5O4, calc. [M+H]
+ = 420.1666) and roquefortine F (4, C23H-
25N5O3, calc. [M+H]
+ = 420.2030)  (Figure 1) is described under various conditions. 
First, structure identification based on identical database entries is shown for sin-
gle, isomeric and isobaric ions, representing identity searches in DI experiments. 
To demonstrate de novo structure identification, in which the mass spectral data of 
the analyte is not represented in a database, the structure elucidation of 1 is shown 




Fragmentation tree generation and database search
Multiple stage fragmentation spectra for each compound were acquired using di-
rect infusion as described in the Materials and Methods section. Due to the gentle 
ionization of ESI, little fragmentation of precursor ions was observed. After elemen-
tal compositions were assigned to all fitting ions present in the acquired fragmenta-
tion tree using a fixed precursor composition, fragment and neutral-loss trees were 
automatically generated. The resulting trees were compared to an in-house MSn da-
tabase searching for similar mass fragments and neutral-losses. Obtained database 
entries were ranked in a descending order according their similarity represented by 
the Tanimoto coefficient (Flower, 1998).
Identity search of single ion trees
The database query of the fragment tree of compound 1, which did not show ad-
ditional abundant ions present in the same isolation range of MS1 prior fragmentati-
on, returned the database entry roquefortine C as most similar hit. As all fragments 
and neutral-losses of compound 1 could be found present and similarly arranged in 
the database entry, an identical structure for both compounds was indicated (Figure 
2). This was supported by comparing their individual multiple stage fragmentation 
spectra showing almost identical mass spectra on every level (data not shown). The-
refore, 1 was tentatively identified as roquefortine C which was ultimately confir-











































Figure 2. Fragment tree comparison without co-fragmented ions
Superimposed fragment trees of 1 (top), acquired from a biological samples using DI-MS, and partial fragmentation 
tree of database entry roquefortine C (back) after fragment tree comparison. All fragments of 1 could be found 
similarly arranged in the database entry (colored nodes) whereas not all fragments of the database entry could 
be found in the fragment tree of 1 (white nodes). Differences between both trees are due to different precursor 
intensities. 
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 






The difference in depth and width between the fragment tree of 1 and roquefortine 
C results from the different precursor intensities during fragmentation tree acquisi-
tion. The tree of 1 was acquired using a complex biological sample with a low con-
centration of 1, whereas the fragmentation tree of roquefortine C in the reference 
database was acquired with a highly concentrated standard resulting in a much ri-
cher fragmentation.
Identity searches of isomeric ion trees
We next investigated the possibility of achieving unambiguous identification of co-
fragmented isomeric precursor ions using CMCP by spiking the isomer 2 to a solu-
tion of 1. With an identical mass-over-charge ratio in MS1, the two isomers 1 and 2 
with m/z 390.1926 (C22H23N5O2, calc. [M+H]
+ = 390.1924) are simultaneously frag-
mented resulting in one single fragmentation tree containing fragments from both 
compounds (Figure 3 and Figure 4A). Due to an identical elemental composition 
of their precursor ions in MS1, all fragments originating from a fragmentation of 
1 and 2 could be assigned with their correct elemental composition when proces-
sed with the chemical formula of protonated 1. This resulted in the incorporation 
of all fragments of 2 into the fragment tree of 1 (Figure 4B).  Using CMCP, the da-
tabase query returned the protonated database entry roquefortine C (C22H23N5O2, 
[M+H]+ = 390.1924)  as most similar hit to 1, sharing a common precursor ion next 
































































































































































Figure 3. Multiple stage fragmentation spectra of the co-fragmented isomers 1 and 2 (left), and the database en-





structurally related (Figure 4C). This was further supported by highly similar MS2 
spectra in which all fragments of roquefortine C were present with a similar mass-
to-charge ratios and relative intensities in the MS2 spectrum of co-fragmented 1 
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286.131 were highly abundant in the 
MS2 of 1 but not present in the MS2 spec-
tra of the database entry roquefortine C, 
resulting in ambiguity about the struc-
ture of 1. With the automatic multiple 
stage fragmentation spectra acquisition 
in CMCP, product ions in MS2 were frag-
mented further yielding fragmentation 
spectra of various fragmentation stages, 
corresponding to a fragmentation of 1 
which were free of interfering ions and 
completely identical to their analogue 
in the database entry roquefortine C. So 
shows the MS3 spectra of m/z 322.131 in 
1 and roquefortine C similar fragments 
in terms of mass-to-charge ratios and 
relative intensities (Figure 3, Figure 4C) 
leading to the conclusion that 1 and ro-
quefortine C are structurally identical. In 
addition, fragments in the fragment tree 
of 1, which were not found to be shared 
by the database entry roquefortine C, 
have to originate from a fragmentation 
of at least one additional isomer, namely 
compound 2 (Figure 4C). 
In addition, as the complete spectral 
information of co-fragmented 2 is con-
tained in the acquired fragmentation tree 
of 1, the identification of 2 can be perfor-
med accordingly from the same multiple 
stage fragmentation data. Using the se-
cond most similar database entry 3-me-
7-(3-methylbenzyl)-8-((1-phenylethyl)
amino)-3,7-dihydro-1H-purine-2,6-dione 
from the database query, which shares 
solely the remaining fragments with the 
fragment tree of 1 and 2, the structure of 
2 could be determined.
These results demonstrate the confident 
identification of analytes in direct infu-
sion using CMCP despite a co-fragmen-
tation of isomeric ions.
Figure 4. Structure elucidation of co-fragmented iso-
mers. Fragment tree comparison for the co-fragmented 
isomers 1 and 2. As both compounds have the same 
elemental composition, all fragments of 2 were assig-
ned with a correct elemental composition when pro-
cessed with the precursor formula of protonated 1. The 
database query returned the database entry roquefor-
tine C as most similar hit, with all fragments of 1 being 
present and similarly arranged. 
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 






Identity searches of isobaric ion trees
When analyzed separately, compound 3 with m/z 420.1659 (C22H21N5O4, cal. [M+H]
+ 
= 420.1666) could be unambiguously identified based on its fragmentation tree, 
following the strategy described for the Identity search of compound 1. However, 
when analyzed in the liquid culture of P. chrysogenum, a compound with a very 
similar mass-over-charge ratio of 420.2024 (4, C23H25N5O3, calc. [M+H]
+ = 420.2030) 
was observed.  
Although clearly distinguishable in MS1, due to the high-resolution of the Orbitrap, 
compound 3 and the interfering isobaric ion of 4 were isolated together and frag-
mented simultaneously due to the insufficient resolving power available in the iso-
lation step. This resulted in an identical fragmentation tree with identical MSn spec-
tra for both compounds, containing fragments originating from a fragmentation of 
3 and 4 (Figure 5). By processing the acquired multiple stage fragmentation spectra 
with the chemical formula of protonated 3, ions originating from a fragmentation 
of 3 were assigned with their correct elemental composition and incorporated into 
the fragmentation tree. In contrast, fragments originating from a fragmentation of 
4 were mainly rejected as their elemental composition was not consistent with the 
chemical formula of 3 (Figure 6A and B). So is the fragment with m/z 389 (C22H-
23N5O2) of 4 and its complete subtree, not present in the fragmentation tree of 3 as 
its corresponding elemental composition contains two additional hydrogens com-







































































































































































Figure 5. Multiple stage fragmentation spectra of the co-fragmented isobars 3 and 4, acquired from a biological 
sample using DI-MS (left), and the database entry glandicoline B (right). Fragments originating from compound 3 




pared to protonated 3. However, due to the relatively similar elemental composi-
tion of 3 and 4, few fragments originating from a fragmentation of 4 could be still 
assigned, like m/z 320 (C17H14N5O2), m/z 350 (C18H16N5O3) and m/z 388 (C22H22N5O2).
The subsequent database query of 3 returned highest similarity to the database en-
Figure 6. Structure elucidation of co-fragmented isobars
Fragment tree comparison of the co-fragmented isobars 3 
and 4. First, an unassigned fragmentation tree containing 
fragments of compound 3 and 4 was obtained. During 
the assignment of elemental compositions to fragments 
using the precursor formula of 3, several fragments ori-
ginating from 4 were rejected due to inconsistency. Last, 
the database query returned the database entry glan-
dicoline B as most similar entry with all fragments of 3 
being present and similarly arranged. The complete frag-
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try glandicoline B (C22H21N5O4, [M+H]
+ 
= 420.16663) which shares next to si-
milarly arranged fragments and neu-
tral-losses also its precursor ion with 
3 (Figure 5 and Figure 6C). MS2 frag-
ments, present in both compounds, 
showed similar subtrees, indicating 
that 3 and glandicoline B share a simi-
lar (sub)structure. This was supported 
by comparing their individual multiple 
stage fragmentation spectra showing 
almost identical relative intensities of 
fragments shared by 3 and glandicoline 
B (Figure 5). Therefore, it is concluded 
that remaining fragments in the frag-
ment tree of 3, which were not found 
shared by the database entry glandico-
line B, correspond to a fragmentation 
of 4 (Figure 6C). The structure of 3 was 
tentatively identified as glandicoline B 
and ultimately confirmed using HPLC-
MS/MS comparing 3 and a chemical 
standard of glandicoline B. 
As 3 and 4 were fragmented simulta-
neously, the structural information of 4 
is contained in the same multiple sta-
ge fragmentation spectra which were 
used to identify 3. By processing the 
fragmentation tree of co-fragmented 3 
and 4 with the elemental composition 
of 4, instead of 3, the fragment and 
neutral-loss tree of 4 were obtained 
(data not shown). Their comparison 
to the MSn database returned roque-
fortine F as most similar database en-
try sharing almost all fragments and 
neutral-losses with 4. Ultimately, 4 was 
tentatively identified as roquefortine F 
which was confirmed using NMR.
The structure identification of co-frag-
mented isobaric ions is comparable to 
the identification of compounds from 
single or isomeric ions, depending on 
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 






the elemental composition and fragmentation of the compounds. In case none 
of the fragments in MS2 of the interfering isobaric compound are consistent with 
the precursor formula of the targeted analyte, a fragment tree without interfering 
fragments is obtained for the analyte resembling the identification of a single frag-
mented compound. If however, both isobars share a similar elemental composition, 
fragments and neutral-losses of the co-fragmented isobaric ions can be incorpora-
ted into the processed trees of the analyte, resembling the fragment and neutral-
loss trees of co-fragmented isomers. Therefore, similar strategies for their identifi-
cation apply. 
In contrast to the identification of one population of structurally identical ions or co-
fragmenting isomeric ions, the presence of isobaric ions is immediately recognized 
as such, as more than one precursor ion in MS1 can be observed if the resolution of 
the mass spectrometer is sufficient enough.  
De novo structure identification 
So far, the structure elucidation shown was achieved using an identical standard 
present in the MSn database. However, an identical database entry is not always 
available, especially when completely new compounds with novel structures were 
discovered. To demonstrate the de novo structure identification of single frag-
mented 1, using not an identical but similar database entry, the database entry 
of 1 (roquefortine C) was removed from the database. Without an identical entry 
present in the database, the database query of 1 with m/z 390 (C22H23N5O2, calc. 
[M+H]+ = 390.1924), returned highest similarity to the database entry dehydrohisti-
dyltryptophanyldiketopiperazine (DHTD) with m/z 322 (C17H15N5O2, calc. [M+H]
+ = 
322.1299), which shares almost its complete fragment and neutral-loss trees with 
1, as well as the database entry roquefortine D with m/z 392 (C22H25N5O2, calc. 
[M+H]+ = 392.2081)  which shares primarily a consecutive neutral-loss path (Figure 
7A and 7B). As both database entries have a different elemental composition as 1, 
it can be immediately concluded that a similar substructure rather than an identi-
cal structure is shared. Based on their shared fragments and neutral-losses, similar 
fragmentation mechanisms could be identified and a (sub)structure of 1 deduced 
(Chapter 5). As all fragments and neutral-losses in the fragment and neutral-loss 
tree of 1 originate from a fragmentation of 1, the remaining unshared fragments 
can be used to validate the deduced structure for consistency, providing additional 
confidence for the proposed structure.
Different to the fragmentation tree of single fragmented 1, in which all fragments 
originate from a fragmentation of 1, the fragmentation tree of the co-fragmented 
isomers 1 and 2 contains additional fragments and neutral-losses from a fragmen-
tation of 2 (Figure 7A and 7B). Although the same fragments and neutral-losses are 
shared with the database entries DHTD and roquefortine C, as shown for 1 without 
a co-fragmented interfering ion, a lower similarity value is obtained due to the addi-
tional unshared fragments and neutral-losses of 2. Based on the shared nodes and 
the known structure of the database entry, a common fragmentation mechanism 
could be identified and a (sub)structure deduced for 1 (Chapter 5). In contrast to 
the previous identification, not all unshared fragments and neutral-losses can now 
be used to support the tentatively identified structure of 1 as they might originate 




identified structure of 1 can give an indication that structurally different fragments 
are present most likely originating from a co-fragmentation of an isomeric precur-
sor ion. 
Comparable to the identity search of co-fragmented isobaric ions, shows the de 
novo structure elucidation of co-fragmented isobars either more similarity to the de 
novo identification of compounds from single ions or isomeric ions, depending on 
the elemental composition and fragmentation of the involved compounds. Althou-
gh the presence of isobaric ions can be clearly recognized based on the presence of 
more than one precursor ion in MS1, it can pose a similar challenge as the de novo 
identification of co-fragmented isomers if all fragments of the interfering isobar can 
be assigned with a valid elemental composition when processing with the molecu-
lar formula of the analyte. Therefore, similar strategies for their identification apply.
 
Conclusions
As a preceding separation step is absent in DI, all ions originating from a particu-
lar sample are, in general, measured at the same time in the mass spectrometer. 
Depending on the composition of the sample, unwanted ions can interfere with 
the compound of interest in form of isobaric or isomeric ions, resulting in their si-
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Figure 7. Schematic de novo identification of compound 1, co-fragmented with the isomer 2, using fragment tree 
comparison to the database entry DHTD (A) and neutral-loss tree comparison to the database entry roquefortine 
D (B). By removing the fragments and neutral-losses of 2, indicated by a dashed square, the de novo identification 
of 1 without a co-fragmented ion can be deduced.
Multiple stage fragmentation tree comparison enables detailed structure elucidation in 






approaches, fragment ions of an analyte can be structurally characterized using the 
Chemoinformatics supported MSn Comparison Pipeline (CMCP) due to consecutive 
isolation and fragmentation allowing their differentiation from ions originating from 
co-fragmenting isobaric or isomeric precursor ions. With the subsequent genera-
tion of fragment and neutral loss trees from the acquired multiple stage fragmen-
tation spectra, sub-trees from co-fragmented isobars can be confidently removed 
resulting in fragmentation data solely originating from the analyte. In cases where 
the sample compound is present in the database, a fully automated identification 
is possible despite co-fragmented interferences enabling detailed structure eluci-
dation in direct-infusion based experiments. This makes CMCP a valuable tool as 
also newer generation mass spectrometer will not be able to completely avoid a 
co-fragmentation of isomeric and isobaric ions.
Furthermore, as CMCP is searching for common fragments and neutral-losses, 
also database entries which don’t fragment in an identical, but similar fashion are 
returned. With the structural elucidation of shared fragments, deduced from the 
known structure of the database entry, confident de novo identification of unknown 
molecular (sub)structures can be achieved, even without the compound being pre-
sent in the database. Therefore, less comprehensive databases are required to co-
ver a large chemical space as not for every analyte an identical standard needs to 
be present in the database. 
With the facile integration into already existing profiling pipelines, structural infor-
mation can be directly obtained from DI experiments, offering more than just a ‘first 
pass’ screening without the immanent need to switch to another platform. 
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Summary, conclusions and perspectives
With the persistent endeavor to provide faster, healthier, cheaper and more tar-
geted drugs, there is a constant need for novel bioactive compounds with new 
chemical scaffolds. Although already exploited for more than a century, plants and 
microorganisms are still assumed as a major source of novel and innovative the-
rapeutic agents with antimicrobial, anticancer, antifungal or immunosuppressive 
properties (Newman and Cragg, 2007). However, classical bio-assay guided drug 
discovery strategies, which were used for the last 70 years, are generally long, cost 
intensive and laborious, with a high rediscovery rate of known natural products, 
which resulted in a mass-withdrawal of pharmaceutical companies from natural 
product discovery over the last years (Zerikly and Challis, 2009). With the substantial 
cost reduction and advances in DNA sequencing, a huge quantity of DNA sequence 
data from a wide variety of organisms is now available, offering novel strategies and 
techniques for the discovery of potentially novel bioactive compounds. Genome 
mining, which screens for genetic sequences possibly encoding enzymes that are 
likely to be involved in the biosynthesis of bioactive natural compounds represents 
such a novel and powerful approach (Zerikly and Challis, 2009). Its combination, for 
instance with heterologous gene expression and comparative metabolite profiling 
have already proven successful for the discovery, isolation and characterization of 
novel bioactive metabolites (Bok, et al., 2006). Although the development of struc-
tural analysis and purification techniques has significantly accelerated the process 
of natural product discovery, metabolite discovery and especially metabolite iden-
tification pose still a major challenge in natural product discovery requiring novel 
techniques and analytical platforms. 
In this thesis the development of an analytical pipeline for the discovery, identifi-
cation and extraction of novel natural products from fungal fermentation cultures 
is described.  With structure elucidation being the major bottleneck, the focus was 
set on the implementation and further development of innovative methods for the 
complete, fast and sensitive identification of complex metabolites. These develo-
ped analytical platforms were successfully applied for the discovery, the identifica-
tion and ultimately the assignment of secondary metabolites to their corresponding 
NRPS genes and gene clusters in the fungus Penicillium chrysogenum.
In Chapter 2, the identification of natural products from a di-modular non-riboso-
mal peptide synthetase (NRPS) cluster in Penicillium chrysogenum and their cor-
responding enzymatic steps are described. With five additional tailoring enzymes 
that modify the initial NPRS product, structures of natural products could not be 
deduced directly from the genetic sequence. Thus, individual deletion of the na-
turally expressed biosynthetic genes was performed followed by comparative me-
tabolite profiling. In order to discover and identify the unknown natural products 
originating from this NRPS cluster, an unbiased, sensitive and fast analytical method 
was required. Using reversed phased liquid chromatography (RP-LC) in combination 
with high resolution and high accuracy mass spectrometry, obtained by a linear 
ion-trap Fourier transform mass spectrometer (LTQ-FTMS), a untargeted metabo-
lite profiling method was developed for the discovery of medium-polar to unpolar 
compounds. Based on a full analytical validation, it was concluded that the method 







was suitable for the detection of novel natural products with good reproducibility, 
linearity, high coverage and high sensitivity enabling metabolite discovery at na-
nomolar levels. This method was therefore used throughout this thesis, enabling 
the discovery of about 40 relevant secondary metabolites from two different NRPS 
clusters in Penicillium chrysogenum (Chapter 2 – 4).
Subsequent LC-MSn and NMR analysis of the discovered metabolites originating 
from the di-modular NRPS revealed astonishing compounds with complex che-
mical scaffolds, harboring among others antimicrobial properties. By linking their 
production in host and derived deletion strains to the performed genetic modifica-
tion, a first step towards the identification of their biosynthetic machinery could be 
achieved. 
In Chapter 3, the structural identification of five lower concentrated products ob-
tained from comparative metabolite profiling of deletion strains from the di-mo-
dular NRPS in Chapter 2 is described. Based on their novel structures missing links 
in the biosynthetic machinery could be filled, revealing that all involved enzymes 
of this pathway are rather unspecific by catalyzing more than one reaction. This 
results in natural products with unusual chemical structures harboring cytotoxic 
and potentially anti-cancer properties. Starting with histidyltryptophanyldiketopi-
perazine (HTD), synthesized by the core synthetase enzyme RoqA using tryptophan 
and histidine as substrates, RoqD catalyzes the biosynthesis of roquefortine D from 
HTD. At the same time, RoqR, a cytochrome p450 oxidoreductase, oxidizes HTD at 
its histidinyl moiety to dehydrohistidyltryptophanyldiketopiperazine (DHTD). Both 
simultaneous reactions of HTD lead to a branch of the roquefortine/meleagrin pa-
thway, one to DHTD via the oxidation by RoqR and further to roquefortine C by 
dimethylallyl addition of RoqD, and the other via an alteration of the enzymatic 
order. There, dimethylallyl addition is first performed by RoqD to yield roquefortine 
D while further oxidation is carried out by RoqR yielding roquefortine C. RoqM, 
encoding a flavin-dependent MAK 1-monooxygenase like protein, was found to 
be involved in the conversion of roquefortine C to roquefortine L, a novel com-
pound containing an unusual nitrone moiety, possibly with a hydroxyroquefortine 
like structure as intermediate. Additionally, Roquefortine F, previously only repor-
ted from a deep ocean sediment derived Penicillium species, is synthesized from a 
consecutive enzymatic modification of RoqM and RoqN on roquefortine C, yielding 
ultimately neoxaline involving RoqO. In addition, RoqN and RoqO were also found 
be involved in the biosynthesis of glandicoline B and meleagrin, however, acting in 
a reversed order. In summary, these results demonstrated the suitability of the de-
veloped pipeline for the discovery and de novo identification of novel metabolites 
from complex biological samples.
  
Next, the metabolite discovery and identification pipeline was successfully applied 
for the investigation of a cryptic non-linear tetra-modular NRPS present in Penicil-
lium chrysogenum, which is described in Chapter 4. By deleting the putative gene 
in combination with comparative metabolite profiling various novel cyclic and linear 
tetrapeptides with similar chemical properties were identified and subsequently 
associated to this NRPS. Based on the sequence of the produced cyclic products, 




tive substrates was deduced resulting in an incorporation of different amino acids 
into the final product. In combination with substrate predictions for each module, 
the detailed mechanism for their production could be determined. This study de-
monstrates the need for comprehensive analytical methods which allow profound 
insight into the metabolome. As the biosynthetic mechanism was deduced from the 
amino acid sequence of the products, comprehensive quantitative and structural 
information of the natural products was required to link each adenylation domain 
correctly to its individual chain extending step. 
However, de novo structure elucidation as applied in Chapter 2 - 4 is a challenging 
task which either offers only limited structural information, as often observed for 
mass spectrometry despite MS/MS fragmentation, or demands high sample purity 
and amounts as required for NMR. To overcome these limitations, first steps to-
wards an automated de novo structure elucidation were taken. In Chapter 5, the 
structure elucidation pipeline CMCP (Chemoinformatics supported MSn Compa-
rison Pipeline), is presented which is based on the comparison of multiple stage 
fragmentation mass spectrometry (MSn) data. After metabolite extraction and high-
resolution fragmentation tree acquisition, fragment and neutral-loss trees of un-
knowns are generated and compared to a MSn database using computational tools 
to extract compounds with similar fragmentation behavior, represented by shared 
fragments and/or neutral-losses. Identifying these shared fragmentation mecha-
nisms, based on the known structure of the database entry, allows to confidently 
deduce chemical (sub)structures of unknowns, even without the need of the un-
known compound to be present in the database. Depending on the results from the 
database query of the unknown compound, similarity can be a result of identical 
or similar fragments, identical or similar neutral-losses or a combination of both. 
To demonstrate the different conceptual outcomes of a database query (similarity 
based on an identical fragment and neutral-loss tree, similarity based on a similar 
fragment and neutral-loss tree, similarity based on a similar neutral-loss tree) and 
to show how this information can be used to deduce structural information, the de 
novo identification of the previously unknown secondary metabolites roquefortine 
C, dehydrohistidyltryptophanyldiketopiperazine (DHTD), roquefortine F and roque-
fortine D, obtained from comparative metabolites profiling, was shown. Their ten-
tatively identified (sub)structures were ultimately confirmed by NMR. 
Traditional approaches for the discovery of metabolites by mass spectrometry use 
chromatographic separation like LC (Liquid Chromatography) before metabolite de-
tection, as described in Chapter 2 - 4. Due to the chromatographic separation step, 
laborious and time consuming sample preparation procedures are required next 
to significant analysis times. Furthermore, separation and detection of metabolites 
is heavily depending on the chemical nature of the analytes and the used chroma-
tographic method. In contrast, direct infusion mass spectrometry (DI-MS) is a fast, 
reliable, sensitive and cost effective method which is particularly attractive when 
dealing with large sample sets. However, structure identification in direct infusion 
based experiments is still a major obstacle due to co-fragmenting interferences like 
isobaric and isomeric ions, limiting most applications to metabolite fingerprinting 
only. In Chapter 6, the further development and application of CMCP for the struc-







ture elucidation of metabolites in direct infusion based experiments was described. 
Similar to the structure elucidation demonstrated in Chapter 5, molecular structu-
res of unknowns are deduced from shared fragmentation mechanisms of similar 
fragmenting database entries. However, in contrast to the structure elucidation pre-
sented in Chapter 5, in which pure sample fractions were used for fragmentation 
tree acquisition, in direct infusion unwanted ions can interfere with the compound 
of interest in form of isobaric or isomeric ions due to a missing preceding chromato-
graphic separation step. As they are fragmented simultaneously, MS2 fragmentation 
spectra with additional fragments are obtained which hamper structural identifi-
cation. However, by fragmenting these fragments further, unwanted fragments of 
interfering ions are removed via successive isolation and fragmentation, resulting in 
subtrees originating ideally from only one population of structurally identical ions, 
as shown for the identification of roquefortine C, roquefortine F and glandicoline 
B. With CMCP searching for common fragments and neutral-losses over various 
fragmentation stages, database entries with similar subtrees were extracted, which 
allowed the structural identification of (sub)structures of the unknown compound, 
even without the compound being present in the database. With the facile inte-
gration of a DI profiling approach, metabolite discovery and identification can be 
combined into one analytical platform, extending DI to more than just a ‘first pass’ 
screening without the immanent need to switch to another platform. 
In conclusion, this thesis demonstrated the development and application of analy-
tical platforms for the discovery, relative quantification and identification of secon-
dary metabolites from Penicillium chrysogenum. Although solely applied to fungal 
liquid cultures, these platforms can be easily extended to meet the requirements 
for the discovery and identification of metabolites from other biological samples.
Especially the utilization of automated fragmentation tree comparison has proven 
to be very powerful for the structural identification of metabolites. Compared to 
traditionally used MS/MS approaches in which product ions are acquired into one 
spectrum, MSn approaches fragment product ions further giving insight into pre-
cursor-product ion relationships. As the structure of a precursor ion is coded in its 
fragments, subtrees contain structural information of their precursors. Thus, the 
comparison of fragments in MSn is not limited to mass-over-charge ratios, elemen-
tal compositions or intensities, but in addition, allows the comparison of fragment 
structures giving a tremendous advantage compared to MS/MS approaches. Besi-
des being clearly beneficial for de novo identifications, as shown in Chapter 5 and 
6, multiple stage fragmentation tree comparison also offers much more confidence 
in traditional identity searches, in which the database entry is present in the data-
base, as fragments and neutral-losses are compared over multiple fragmentation 
stages rather than only on one level. Therefore, it is expected that MSn methods will 
more and more replace MS/MS based approaches in the near future in cases where 
detailed structural information of analytes is needed but only limitedly available. 
However, due to much longer acquisition times of MSn experiments compared to 
MS/MS approaches, complete fragmentation trees can’t be always generated on 
the fly during metabolite profiling with the current generation of mass spectro-
meters. Therefore, methods like on the fly fraction collection followed by direct 




mass spectrometry without prior separation, as described in Chapter 6 or repeti-
tive HPLC-MSn experiments in which specific subtrees of a fragmentation tree are 
acquired during each run which are ultimately assembled to a complete tree, can be 
combined with existing profiling approaches to efficiently integrate multiple stage 
fragmentation tree comparison into profiling platforms.
However, it should be pointed out that comparison of fragmentation trees is still a 
time consuming task which requires profound chemical knowledge of fragmenta-
tion mechanisms. If not a completely identical but a merely similar database entry 
was obtained from fragmentation tree comparison, individual fragmentation me-
chanisms, shared by both compounds, had to be identified based on the known 
structure of the database entry, as described in Chapter 5. Unfortunately, the know-
ledge of fragmentation mechanisms obtained by chemical induced dissociation 
(CID), which was used to enable multiple stage fragmentation, is still limited and 
cannot be exactly predicted with algorithms, although software packages and algo-
rithms are available to predict to some extent fragmentation. Different to fragmen-
tation obtained from electron ionization (EI, formerly known as electron impact) 
which is extensively described in literature, the identification of fragments obtained 
by CID is still often done manually by experts. However, with larger MS2 and MSn 
databases becoming available, it is expected that mining these databases can lead 
to a deeper understanding of collision induced dissociation mechanisms, which can 
be translated into exact fragmentation predictions, ultimately accelerating mass 
spectrometry based structure elucidation. An alternate approach is the structural 
elucidation of fragments and neutral-losses in database entries by MS experts. By 
storing detailed structures of nodes into the MSn database, structures of similar no-
des present in unknown target compounds can be automatically assignment in later 
database queries, enabling an immediate identification of fragments and neutral-
losses without further intervention of MS experts. By automatically combining the 
structural overlap of various subtrees or neutral-losses from one or more similar 
database entries, complete (sub)structures could be deduced allowing a completely 
automated structure identification. Thus, multiple stage fragmentation tree compa-
rison is an extremely valuable identification approach which is expected to have a 
substantial impact on metabolite identification. Especially in natural product drug 
discovery, which aims to find novel natural products with completely new chemical 
scaffolds, which are not present in any database, multiple stage fragmentation tree 
comparison offers a fast, sensitive, cost effective and reliable solution.
With combinatorial chemistry failed to deliver leads that form the basis for deve-
lopment of successful new drugs, other strategies need to be found for drug disco-
very. With the substantial cost reduction and advances in DNA sequencing, a huge 
quantity of DNA sequence data from a wide variety of organisms became available 
opening new possibilities in natural product drug discovery, like shown in Chapter 
2 - 4. As the tremendous increase in genome mining based studies over the last 
years already indicates, a resurgence of interest in natural product drug discovery is 
expected. However, the majority of these studies is very suggestive and confined as 
their metabolite discovery step is limited due to the used analytical methods. Espe-
cially the prevalent application of spectroscopy based detection methods like UV-







Vis heavily reduces the amount of detectable metabolites, as only a limited number 
of analytes absorb light within the UV-Vis range efficiently. In addition, commonly 
targeted methods are used for metabolite discovery which allow solely a detection 
of selected metabolites. Novel products or intermediates obtained from genetic 
modifications are, however, mostly completely neglected. 
Therefore, different analytical tools are necessary to obtain comprehensive chemi-
cal information which requires experts from different analytical fields like metabo-
lite profiling (on GC, LC, CE coupled to UV-Vis, MS etc.), metabolite identification 
(MSn, NMR, etc.), statistical analysis and chemoinformatics working closely together 
in a state of the art environment. Next to a high level of expertise, efficient, coordi-
nated and structured processes are required to ultimately answer urgent biological, 
pharmacological or medicinal questions using the appropriate analytical techno-
logy and strategies.
However, extensive cooperation is not only limited to the analytical part. As geno-
me-based metabolite discovery combines multiple disciplinary processes like ge-
nome mining, genetic modification, comparative metabolite profiling, metabolite 
identification, pathway construction, bioactivity testing etc., scientific experts from 
each discipline are required to efficiently cooperate to unravel the mechanisms of 
secondary metabolite formation and the bioactivity of intermediates and products 
produced. It is expected that such collaborations will allow to discover and identify 
novel bioactive natural products for the development of new medicines.
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Met het aanhoudende streven naar snellere, gezondere, goedkopere en meer ge-
richte geneesmiddelen, is het noodzakelijk en erg belangrijk om nieuwe bioactieve 
verbindingen en chemische samenstellingen te identificeren. Planten en micro-or-
ganismen worden al meer dan een eeuw gebruikt als één van de belangrijkste bron-
nen voor nieuwe en innovatieve therapeutische middelen met een anti-kanker, anti-
schimmel of immuun onderdrukkende werking (Newman and Cragg, 2007). Echter 
de klassieke bio-assays welke de laatste 70 jaar zijn toegepast voor het ontdekken 
van gerichte geneesmiddelen zijn tijdrovend, kostbaar en erg omslachtig. Verder is 
de kans erg groot dat een al eerder bekend natuurlijk product wordt herontdekt. 
Mede hierdoor is de laatste jaren een afname in de interesse van farmaceutische 
bedrijven geconstateerd voor de ontdekking en ontwikkeling van natuurlijke pro-
ducten (Zerikly and Challis, 2009). Door de aanzienlijke kostenbesparing en vooruit-
gang in de DNA sequentietechnieken is er een grote hoeveelheid DNA sequentiege-
gevens voor een verscheidenheid aan organismen beschikbaar gekomen waardoor 
er nieuwe strategieën en technieken zijn voor de ontdekking van nieuwe bioac-
tieve verbindingen. Het zogenoemde “genome mining” zorgt voor de screening van 
genetische sequenties om zo mogelijke enzymen te identificeren welke betrokken 
zijn bij de biosynthese van bioactieve natuurlijke verbindingen, wat zorgt voor een 
krachtige aanpak (Zerikly and Challis, 2009). De combinatie met bijvoorbeeld hete-
rologe genexpressies en vergelijkende metabolietprofielen heeft al bewezen suc-
cesvol te zijn voor de ontdekking, isolatie en karakterisering van nieuwe bioactieve 
metabolieten (Bok et al., 2006). De ontwikkeling van structuuranalysetechnieken en 
zuiveringstechnieken hebben een significante sprong genomen in het proces van de 
natuurlijke product ontdekking, metaboliet ontdekking en vooral in de metaboliet 
identificering maar vormen nog steeds een belangrijke uitdaging in de ontdekking 
van natuurlijke producten waarvoor nieuwe technieken en analytische methoden 
nodig zijn.
In dit proefschrift beschrijven we de ontwikkeling van een analytische “pipeline” 
voor de ontdekking, isolatie en identificatie van nieuwe natuurlijke producten uit 
schimmelfermentatie-culturen. Omdat de opheldering van moleculaire structuren 
altijd een belangrijk knelpunt is geweest, lag de focus van dit onderzoek voorna-
melijk op de ontwikkeling en toepassing van innovatieve methoden voor complete, 
snelle en gevoelige identificatie van complexe metabolieten. De ontwikkelde ana-
lytische platforms werden met succes toegepast bij de ontdekking en identificatie 
van secundaire metabolieten. Hierdoor konden deze structuren uiteindelijk geasso-
cieerd worden aan de gerelateerde di-modular non-ribosomal peptide synthetase 
(NRPS) genen en genenclusters in de schimmel Penicillium chrysogenum.
In Hoofdstuk 2 beschrijven we de identificatie van natuurlijke producten van een 
di-modulair non-ribosomaal peptide synthetase (NRPS) cluster en de daarbij beho-
rende enzymatische omzettingen in Penicillium chrysogenum. Aangezien het niet 
mogelijk was om, gebruik makend van vijf specifieke enzymen die de originele NRPS 
producten modificeren, de structuren van deze verbindingen te herleiden en deze 
te associeëren aan de genetische informatie, is een vergelijkende metaboliet identi-







ficatie studie uitgevoerd in schimmelculturen waar individuele genen, verantwoor-
delijk voor de biosynthese, werden verwijderd of ge-inactieveerd. Om onbekende 
natuurlijke producten, afkomstig van deze NRPS clusters, te herkennen en te iden-
tificeren is een gevoelige en snelle analytische methode vereist. Door gebruik te 
maken van “omgekeerde fase” vloeistof chromatografie (RP-LC) in combinatie met 
een hoge resolutie en hoge nauwkeurigheid massaspectrometer (linear ion-trap 
Fourier transform mass spectrometer (LTQ-FTMS)) werd er een metaboliet profile-
ringsmethode ontwikkeld om medium-polaire en apolaire stoffen op te sporen. Na 
volledige analytische validatie concluderen we dat deze methode, met een goede 
reproduceerbaarheid, lineariteit en gevoeligheid, geschikt is voor de detectie van 
nieuwe natuurlijke producten waarmee een breed spectrum aan metabolieten op 
het nanomolair concentratie niveau aantoonbaar is. Deze methode is, zoals om-
schreven in dit proefschrift, verder gebruikt bij het onderzoek om circa 40 relevante 
secundaire metabolieten te ontdekken en te identificeren in twee verschillende 
NRPS clusters in Penicillium chrysogenum (Hoofdstuk 2-4).
De gevonden metabolieten, afkomstig van het di-modulaire NRPS, werden later ge-
analyseerd met behulp van LC-MSn en NMR en lieten verrassende en complexe che-
mische verbindingen zien met onder andere antimicrobiële eigenschappen. Door 
hierna de synthese van deze structuren in de gastheer en de bijbehorende deletie-
stammen te koppelen aan de uitgevoerde genetische modifcatie is een eerste stap 
gezet in de opheldering van hun complexe biosynthese route.
In Hoofdstuk 3 identificeren we de structuren van vijf, in lage concentraties aan-
wezige, producten welke gevonden zijn in de vergelijkende metaboliet profilerings-
methode van de deletiestammen zoals beschreven in Hoofstuk 2. Gebaseerd op 
deze nieuwe structuren konden de missende stappen in de biosynthese opgevuld 
worden. Hier zagen we dat de betrokken enzymen niet specifiek zijn maar meer-
dere reacties kunnen katalyseren. Dit resulteerde in de vorming van natuurlijke pro-
ducten met ongebruikelijke chemische structuren welke cytotoxische en potentieel 
anti-kanker gerelateerde eigenschappen hebben. Uitgaande van histidyltryptopha-
nyldiketopiperazine (HTD), dat gesynthetiseerd wordt uit tryptophan en histidine 
door het primaire enzym synthetase RoqA, wordt uiteindelijk roquefortine D ge-
vormd door het enzym RoqD. Tegelijkertijd oxideert RoqR (een cytochroom p450 
oxido-reductase) de histidinyl groep van HTD, waarbij dehydrohistidyltryptophanyl-
diketopiperazine (DHTD) wordt gevormd. Beide gelijktijdige reacties van HTD leiden 
tot een vertakking van de roquefortine/meleagrin route. Hierbij leidt één tak naar 
DHTD, via de oxidatie door RoqR, en verder naar roquefortine C door de toevoeging 
van een dimethylallyl groep door RoqD. In de tweede route is de dimethylallyl groep 
eerst toegevoegd door RoqD om roquefortine D te vormen, dat hierna  wordt geoxi-
deerd tot roquefortine C door RoqR. RoqM bestaat uit een flavine-afhankelijke MAK 
1-mono-oxygenase gelijkend eiwit en is betrokken bij de omzetting van roquefor-
tine C naar roquefortine L, een nieuwe verbinding met een ongebruikelijke nitron 
groep en een mogelijke hydroxyroquefortine-achtige structuur als intermediair. Ro-
quefortine F, een component voorheen alleen beschreven in Penicillium soorten uit 
de diepe oceaan, wordt gesynthetiseerd door een opeenvolging van enzymatische 
modificatie door RoqM en RoqN op roquefortine C, wat uiteindelijk leidt tot de 




de biosynthese van glandicoline B en meleagrin; alleen werken de enzymen dan in 
omgekeerde volgorde. Kortom, deze resultaten demonstreren de geschiktheid van 
de ontwikkelde “pipeline”, voor de ontdekking en de-novo identificatie van nieuwe 
metabolieten, in complexe biologische monsters.
In Hoofdstuk 4 hebben we de metaboliet ontdekking en identificatie “pipeline” 
succesvol toegepast bij het onderzoek naar de structuur van een cryptisch niet-
linear tetra-modular NRPS in Penicillium chrysogenum. Hier hebben we verschil-
lende nieuwe cyclische en lineaire tetrapeptides (een peptide bestaande uit vier 
aminozuren) met gelijke chemische eigenschappen, geïdentificeerd door gebruik te 
maken van een deletie in een enkel gen in combinatie met de vergelijkende meta-
boliet profileringsmethode. Doordat gebruik gemaakt is van de sequenties van de 
gevormde cyclische producten werd een zekere mate van aspecificiteit van alle be-
trokken adenylatie-domeinen in relatie tot hun substraten herleid, waardoor deop-
name van verschillende aminozuren in het eindproduct kan worden verklaard. Door 
gebruik te maken van substraat voorspelling is er voor elk molecuul een gedetail-
leerde synthese route herleid. Deze studie laat zien dat een uitgebreide analytische 
methode noodzakelijk is om meer inzicht in het metaboloom krijgen. Aangezien 
het mechanisme van de biosynthese is afgeleid van de aminozuursequentie van de 
producten, is er volledige kwantitatieve en structurele informatie van de natuurlijke 
producten nodig om elk adenylatie-domein te kunnen verbinden met de individu-
ele ketenverlengingstap. 
Echter, de-novo structuuropheldering met MS zoals is toegepast in Hoofdstuk 2-4 is 
een uitdagende taak die, ondanks MS/MS fragmentatie, tot op heden nog beperkte 
structurele informatie oplevert. Hiernaast heeft structuuropheldering met behulp 
van NMR een hoge zuiverheid van het monster nodig. Om deze problemen op te los-
sen hebben we de eerste stappen gezet naar een geautomatiseerde de-novo struc-
tuuropheldering. In Hoofdstuk 5 beschrijven we de structuurophelderings “pipe-
line” CMCP (chemoinformatics supported MSn comparison pipeline). Deze CMCP is 
gebaseerd op de vergelijking van gegevens uit opeenvolgende fragmentatie massa-
spectrometrie experimenten (MSn). Na isolatie van de metaboliet uit het biologisch 
monster, wordt van deze opgezuiverde fractie een serie opeenvolgende hoge-reso-
lutie fragmentatiespectra opgenomen. Vanuit deze spectra worden fragmentatie- 
en ‘neutral loss’ bomen gegenereerd en vergeleken met een database die gevuld is 
met fragmentatie- en ‘neutral loss’ bomen van bekende verbindingen. Middels soft-
ware kunnen overeenkomstige fragmentaties of ‘neutral losses’ worden herkend. 
Deze overeenkomstige fragmentatie, gebaseerd op de bekende structuur uit de da-
tabase, maakt het mogelijk om zo de structuren van onbekende componenten met 
grote zekerheid te herleiden. Dit werkt ook zonder dat de verbinding daadwerkelijk 
aanwezig is in de database. Afhankelijk van de database query resultaten van de 
onbekende verbindingen, kunnen zowel specifieke fragmenten of ‘neutral losses’ 
identiek zijn, of beiden. Om aan te tonen dat er verschillende conceptuele uitkom-
sten van de database query mogelijk zijn (vergelijkingen gebaseerd op een identiek 
fragment en “neutral-loss” boom) en om te laten zien hoe deze informatie gebruikt 
kan worden, is de-novo structuuridentificatie van de eerder gevonden onbekende 
secundaire metabolieten roquefortine C, dehydrohistidyltryptophanyldiketopipera-







zine (DHTD), roquefortine F en roquefortine D succesvol uitgevoerd. Deze voorlopig 
geïdentificeerde (sub)structuren zijn uiteindelijk bevestigd met NMR.
De traditionele benaderingen voor het opsporen van metabolieten, met behulp van 
massaspectrometrie, gebruiken vloeistof chromatografie (LC) voorafgaand aan de 
metaboliet detectie, zoals is beschreven in Hoofdstuk 2-4. Door gebruik te maken 
van deze chromatografie-stap zijn er arbeidsintensieve en tijdrovende monster-
voorbereidingsstappen nodig, evenals significant lange analysetijden. Bovendien is 
de scheiding en detectie van de metabolieten sterk afhankelijk van de chemische 
aard van de te bepalen stoffen en de gebruikte chromatografische methode. Daar-
entegen is directe infusie massaspectrometrie (DI-MS) een snelle, betrouwbare, ge-
voelige en kosteneffectieve methode die bijzonder aantrekkelijk is als het gaat om 
grote aantallen monsters. Echter, structuuridentificatie gebruik makend van directe 
infusie, is nog steeds moeizaam, zo niet onmogelijk  aangezien co-fragmentatie van 
isobaren en isomeren deze toepassing beperken tot het enkel creëren van een vin-
gerafdruk van een enkele metaboliet. In Hoofdstuk 6 beschrijven we de ontwikke-
ling en toepassing van CMCP in combinatie met directe infusie voor de structuur-
opheldering van metabolieten. Vergelijkbaar met de identificatie van metabolieten 
zoals beschreven in Hoofdstuk 5, zijn de moleculaire structuren van onbekende 
metabolieten afgeleid van overeenkomstige fragmentatiemechanismen van gelijk-
soortig fragmenterende verbindingen in de database. Echter, in tegenstelling tot 
de structuuropheldering, zoals beschreven in hoofdstuk 5, waarbij een gezuiverde 
fractie van het monster werd gebruikt voor het opnemen van de fragmentatieboom, 
kunnen bij directe infusie ongewenste ionen, zoals isobaren en isomeren, de struc-
tuuropheldering belemmeren omdat er geen gebruik wordt gemaakt van de chro-
matografische voor-scheiding. Deze isobaren en isomeren zullen gelijktijdig worden 
gefragmenteerd met de te identificeren verbinding waardoor het MS2 fragmentatie 
spectrum extra fragmentionen bevat die de structuuropheldering belemmeren. Om 
dit te voorkomen hebben we deze fragmentionen verder gefragmenteerd tot 3-de 
generatie fragmenten. De op deze wijze verkregen substructuren zijn idealiter af-
komstig uit slechts één populatie van structureel identieke ionen. Dit laten we zien 
we voor de identificatie van roquefortine C, roquefortine F en glandicoline B. Door 
met CMCP naar overeenkomende fragmenten en “neutral-losses” in de verschil-
lende fragmentatiespectra te zoeken, konden de gelijke substructuren van de in 
de database aanwezige verbindingen en structuren herkend worden. Aan de hand 
van deze identieke (sub)structuren is de structuur van de onbekende verbinding 
herleid. Dit was zelfs mogelijk als deze verbinding niet in de database aanwezig was. 
Door de integratie van directe infusie en de metaboliet ontdekking en identifica-
tie “pipeline” wordt een analytisch platform gecreerd waarbij naast screening ook 
identificatie van onbekende structuren kan worden uitgevoerd.
Tot slot, laten we in dit proefschrift de ontwikkeling en toepassing van analytische 
platformen zien voor de ontdekking, relatieve kwantificering en identificatie van se-
cundaire metabolieten in Penicillium chrysogenum. Alhoewel we dit alleen hebben 
toegepast in schimmelculturen kunnen deze platformen eenvoudig worden toege-





Vooral het gebruik van de geautomatiseerde fragmentatieboom vergelijking heeft 
laten zien dat dit een erg krachtige methode is voor de structuuridentificatie van 
metabolieten. Als we dit vergelijken met de traditionele toegepaste MS/MS benade-
ring waarbij fragment ionen worden gebruikt in slechts één spectrum geeft de MSn 
benadering meerdere lagen van fragment ionen en meer inzicht in de precursor-
fragment ion relatie. Omdat de structuur van de precursor  is verdeeld in fragmen-
ten geven deze subfragmentatiebomen structurele informatie over de precursors. 
Het vergelijk van de fragmenten in MSn is niet gelimiteerd tot de massa-over-lading 
ratio’s, elementaire samenstellingen of intensiteiten en laat een vergelijking van 
fragment structuren zien welke vele voordelen biedt ten opzichte van de MS/MS 
benadering. Naast het duidelijke voordeel voor de-novo identificaties zoals is be-
schreven in Hoofdstuk 5 en 6 geeft de meerdere lagen fragmentatieboom vergelij-
king meer betrouwbaarheid in identiteitsonderzoeken van verbindingen, omdat de 
fragmenten en ”neutral losses” vergeleken over meerdere fragmentatie lagen meer 
informatie bieden dan een enkele fragmentatie. Daarom denken wij dat MSn me-
thoden in de nabije toekomst meer en meer de MS/MS methoden zullen vervangen 
in onderzoeken waar gedetailleerde informatie van een metaboliet nodig is. Echter 
door de langere meettijden van de MSn experimenten vergeleken met de MS/MS 
kunnen de complete fragmentatiebomen niet altijd gemaakt worden gedurende de 
metaboliet profiel metingen met de huidige generatie massaspectrometers. Daar-
om zijn de methoden die “on the fly” directe fractie collectie gecombineerd met 
directe infusie massaspectrometrie zoals gedaan kan worden met de Advion Nano-
mate en beschreven in Hoofstuk 6 belangrijke methoden voor het efficiënt bepalen 
van een complete fragmentatieboom.
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